UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

√	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, ~~2017~~2018

☐	T~~RANSITION~~TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from

Commission file number: 0-52577

(Exact Name of Registrant as Specified in Its Charter)

Delaware		20-3340900
(State or Other Jurisdiction of		(IRS Employer Identification No.)
Incorporation or Organization)

8235 Forsyth Blvd., Suite 400

St. Louis, Missouri 63105

(Address of Principal Executive Offices)

(314) 854-8352

(~~Registrant~~’s Registrant’s Telephone Number, Including Area Code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes √ No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes √ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer ☐	Accelerated filer	√
Non-accelerated filer ☐	Smaller reporting	☐
(do not check if a smaller reporting company)	company

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No √

Indicate the number of shares outstanding of each of the ~~issuer~~’sissuer’s classes of common stock, as of August 9, ~~2017: 43,749,970~~ 2018: 43,742,677

PART I FINANCIAL INFORMATION

Item 1. Financial Statements.

The following sets forth our unaudited consolidated balance sheet as of June 30, ~~2017,~~2018, our audited consolidated balance sheet as of December 31, ~~2016,~~2017, our unaudited consolidated statements of operations and comprehensive income for the three-month and six-month periods ended June 30, ~~2017~~2018 and ~~June 30, 2016,~~2017, and our unaudited consolidated statements of cash flows for the six-month periods ended June 30, ~~2017~~2018 and ~~2016.~~2017.

FutureFuel Corp.

Consolidated Balance Sheets

As of June30, ~~2017~~2018 and December 31, ~~2016~~2017

(Dollars in thousands)

(Unaudited)

June 30, 2017

December 31, 2016

Assets

Cash and cash equivalents
$ 111,010 $ 199,272
Accounts receivable, inclusive of the blenders' tax credit of $0 and $5,495 and net of allowances for bad debt of $0 and $0, at June 30, 2017 and December 31, 2016, respectively
18,746 24,359
Accounts receivable – related parties
2,958 385
Inventory
36,889 52,093
Income tax receivable
16,246 20,508
Prepaid expenses
1,068 1,694
Prepaid expenses – related parties
19 12
Marketable securities
120,728 106,146
Deferred financing costs
144 144
Other current assets
395 669
Total current assets
308,203 405,282
Property, plant and equipment, net
113,868 118,152
Intangible assets
1,408 1,408
Deferred financing costs
253 325
Other assets
3,857 3,876
Total noncurrent assets
119,386 123,761
Total Assets
$ 427,589 $ 529,043
Liabilities and Stockholders’ Equity

Accounts payable
$ 17,649 $ 22,799
Accounts payable – related parties
1,779 1,254
Deferred revenue – short-term
6,061 5,530
Contingent liability – short-term
1,151 1,151
Dividends payable
5,250 110,688
Accrued expenses and other current liabilities
3,855 2,485
Accrued expenses and other current liabilities – related parties
- 142
Total current liabilities
35,745 144,049
Deferred revenue – long-term
14,289 16,792
Other noncurrent liabilities
3,374 3,325
Noncurrent deferred income tax liability
32,438 32,064
Total noncurrent liabilities
50,101 52,181
Total liabilities
85,846 196,230
Commitments and contingencies:

Preferred stock, $0.0001 par value, 5,000,000 shares authorized, none issued and outstanding
- -
Common stock, $0.0001 par value, 75,000,000 shares authorized, 43,749,970 and 43,749,970, issued and outstanding as of June 30, 2017 and December 31, 2016, respectively
4 4
Accumulated other comprehensive income
7,499 3,540
Additional paid in capital
281,828 281,087
Retained earnings
52,412 48,182
Total stockholders’ equity
341,743 332,813
Total Liabilities and Stockholders’ Equity
$ 427,589 $ 529,043

	(Unaudited)
	June 30, 2018		December 31, 2017
Assets
Cash and cash equivalents	$	199,921	$	114,627
Accounts receivable, net of allowances for bad debt of $0 and $0, at June 30, 2018 and December 31, 2017, respectively		22,390		21,973
Accounts receivable – related parties		176		165
Inventory		47,521		43,754
Income tax receivable		3,481		6,937
Prepaid expenses		954		1,660
Prepaid expenses – related parties		12		12
Marketable securities		91,564		120,699
Deferred financing costs		144		144
Other current assets		789		387
Total current assets		366,952		310,358
Property, plant and equipment, net		105,098		109,735
Intangible assets		1,408		1,408
Deferred financing costs		108		180
Other assets		3,845		3,882
Total noncurrent assets		110,459		115,205
Total Assets	$	477,411	$	425,563
Liabilities and Stockholders’ Equity
Accounts payable	$	34,712	$	18,396
Accounts payable – related parties		781		1,183
Deferred revenue – short-term		5,692		2,736
Dividends payable		5,250		10,498
Accrued expenses and other current liabilities		7,052		2,468
Total current liabilities		53,487		35,281
Deferred revenue – long-term		17,142		16,522
Other noncurrent liabilities		1,129		1,115
Noncurrent deferred income tax liability		17,160		21,049
Total noncurrent liabilities		35,431		38,686
Total liabilities		88,918		73,967
Commitments and contingencies:
Preferred stock, $0.0001 par value, 5,000,000 shares authorized, none issued and outstanding		-		-
Common stock, $0.0001 par value, 75,000,000 shares authorized, 43,742,677 and 43,741,670, issued and outstanding as of June 30, 2018 and December 31, 2017, respectively		4		4
Accumulated other comprehensive income		145		8,433
Additional paid in capital		282,178		281,964
Retained earnings		106,166		61,195
Total stockholders’ equity		388,493		351,596
Total Liabilities and Stockholders’ Equity	$	477,411	$	425,563

The accompanying notes are an integral part of these financial statements.

FutureFuel Corp.

Consolidated Statements of Operations and Comprehensive Income

For the Three~~Months~~ and Six ~~Months Ended~~Months ended June 30, ~~2017~~2018 and ~~2016~~2017

(Dollars in thousands, except per share amounts)

(Unaudited)

Three months ended June 30,

Six months ended June 30,

2017

2016

2017

2016

Revenue
$ 67,972 $ 65,842 $ 121,620 $ 109,046
Revenues – related parties
76 2,037 539 5,468
Cost of goods sold
60,227 57,118 104,381 90,276
Cost of goods sold – related parties
5,217 1,914 8,115 3,435
Distribution
769 768 1,658 1,565
Distribution – related parties
37 107 77 213
Gross profit
1,798 7,972 7,928 19,025
Selling, general, and administrative expenses

Compensation expense
1,030 1,277 2,294 2,443
Other expense
505 540 1,085 1,163
Related party expense
44 41 100 89
Research and development expenses
845 738 1,600 1,425
2,424 2,596 5,079 5,120
Income/(loss) from operations
(626 ) 5,376 2,849 13,905
Interest and dividend income
1,991 1,464 3,714 2,809
Interest expense
(43 ) (42 ) (86 ) (85 )
Gain/(loss) on marketable securities
(438 ) 613 (569 ) (405 )
Other expense
(2 ) (104 ) (33 ) (220 )
1,508 1,931 3,026 2,099
Income before income taxes
882 7,307 5,875 16,004
Provision/(benefit) for income taxes
48 (6,917 ) 1,645 (8,789 )
Net income
$ 834 $ 14,224 $ 4,230 $ 24,793

Earnings per common share

Basic
$ 0.02 $ 0.33 $ 0.10 $ 0.57
Diluted
$ 0.02 $ 0.33 $ 0.10 $ 0.57
Weighted average shares outstanding

Basic
43,665,171 43,527,857 43,641,038 43,501,599
Diluted
43,675,688 43,528,759 43,649,400 43,507,509

Comprehensive Income

Net income
$ 834 $ 14,224 $ 4,230 $ 24,793
Other comprehensive income from unrealized

net gain on available-for-sale securities
3,210 1,349 6,096 2,027
Income tax effect
(1,126 ) (472 ) (2,137 ) (710 )
Total unrealized gain, net of tax
2,084 877 3,959 1,317
Comprehensive income
$ 2,918 $ 15,101 $ 8,189 $ 26,110

	Three months ended June 30,						Six months ended June 30,
	2018			2017			2018			2017
Revenue	$	87,653		$	67,972		$	142,596		$	121,620
Revenues – related parties		683			76			1,487			539
Cost of goods sold		73,218			60,227			85,357			104,381
Cost of goods sold – related parties		5,302			5,217			10,031			8,115
Distribution		1,498			769			2,817			1,658
Distribution – related parties		47			37			100			77
Gross profit		8,271			1,798			45,778			7,928
Selling, general, and administrative expenses
Compensation expense		846			1,030			2,121			2,294
Other expense		596			505			1,006			1,085
Related party expense		205			44			278			100
Research and development expenses		784			845			1,966			1,600
		2,431			2,424			5,371			5,079
Income/(loss) from operations		5,840			(626	)		40,407			2,849
Interest and dividend income		2,153			1,991			4,145			3,714
Interest expense		(43	)		(43	)		(86	)		(86	)
Gain/(loss) on marketable securities		281			(438	)		(4,088	)		(569	)
Other expense		(177	)		(2	)		(177	)		(33	)
		2,214			1,508			(206	)		3,026
Income before income taxes		8,054			882			40,201			5,875
Provision/(benefit) for income taxes		2,003			48			(1,676	)		1,645
Net income	$	6,051		$	834		$	41,877		$	4,230

Earnings per common share
Basic	$	0.14		$	0.02		$	0.96		$	0.10
Diluted	$	0.14		$	0.02		$	0.96		$	0.10
Weighted average shares outstanding
Basic		43,716,726			43,665,171			43,716,698			43,641,038
Diluted		43,720,942			43,675,688			43,721,568			43,649,400

Comprehensive Income
Net income	$	6,051		$	834		$	41,877		$	4,230
Other comprehensive income/(loss) from unrealized net
gains/(losses) on available-for-sale securities		55			3,210			(19	)		6,096
Income tax effect		(12	)		(1,126	)		4			(2,137	)
Total unrealized gain/(loss), net of tax		43			2,084			(15	)		3,959
Comprehensive income	$	6,094		$	2,918		$	41,862		$	8,189

The accompanying notes are an integral part of these financial statements.

FutureFuel Corp.

Consolidated Statements of Cash Flows

For theThree and Six Months~~Ended~~ ended June 30, ~~2017~~2018 and ~~2016~~2017

(Dollars in thousands)

(Unaudited)

Six months ended June 30,

2017

2016

Cash flows provided by operating activities

Net income
$ 4,230 $ 24,793
Adjustments to reconcile net income to net cash provided by operating activities:

Depreciation
5,808 5,257
Amortization of deferred financing costs
72 72
Benefit for deferred income taxes
(1,763 ) (4,969 )
Change in fair value of derivative instruments
318 4,869
Other than temporary impairment of marketable securities
177 1,879
Impairment of fixed assets
9 178
Gain/(loss) on the sale of investments
392 (1,474 )
Stock based compensation
750 954
Losses on disposals of fixed assets
77 137
Noncash interest expense
13 22
Changes in operating assets and liabilities:

Accounts receivable
5,613 21,708
Accounts receivable – related parties
(2,573 ) (23 )
Inventory
15,204 6,240
Income tax receivable
4,262 (2,818 )
Prepaid expenses
626 589
Prepaid expenses – related party
(7 ) -
Accrued interest on marketable securities
(11 ) (104 )
Other assets
19 (321 )
Accounts payable
(5,150 ) (17,948 )
Accounts payable – related parties
525 1,584
Accrued expenses and other current liabilities
1,370 2,470
Accrued expenses and other current liabilities – related parties
(142 ) -
Deferred revenue
(1,972 ) 2,933
Other noncurrent liabilities
112 -
Net cash provided by operating activities
27,959 46,028
Cash flows from investing activities

Collateralization of derivative instruments
(34 ) (3,011 )
Purchase of marketable securities
(19,322 ) (32,299 )
Proceeds from the sale of marketable securities
10,268 16,524
Capital expenditures
(1,686 ) (2,254 )
Net cash used in investing activities
(10,774 ) (21,040 )
Cash flows from financing activities

Minimum tax withholding on stock options exercised and awards vested
(8 ) (55 )
Excess tax benefits associated with stock options and awards
(1 ) (136 )
Payment of dividends
(105,438 ) (5,246 )
Net cash used in financing activities
(105,447 ) (5,437 )
Net change in cash and cash equivalents
(88,262 ) 19,551
Cash and cash equivalents at beginning of period
199,272 154,049
Cash and cash equivalents at end of period
$ 111,010 $ 173,600

Cash paid for interest
$ - $ -
Cash paid for income taxes
$ 55 $ 985

	Six months ended June 30,
	2018			2017
Cash flows provided by operating activities
Net income	$	41,877		$	4,230
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation		5,512			5,808
Amortization of deferred financing costs		72			72
Benefit for deferred income taxes		(3,885	)		(1,763	)
Change in fair value of equity securities		6,412			-
Change in fair value of derivative instruments		(1,559	)		318
Other than temporary impairment of marketable securities		-			177
Impairment of fixed assets		171			9
Gain on the sale of investments		(2,324	)		392
Stock based compensation		214			750
Losses on disposals of fixed assets		37			77
Noncash interest expense		14			13
Changes in operating assets and liabilities:
Accounts receivable		(417	)		5,613
Accounts receivable – related parties		(11	)		(2,573	)
Inventory		(3,767	)		15,204
Income tax receivable		3,456			4,262
Prepaid expenses		706			626
Prepaid expenses – related parties		-			(7	)
Accrued interest on marketable securities		(82	)		(11	)
Other assets		39			19
Accounts payable		16,316			(5,150	)
Accounts payable – related parties		(402	)		525
Accrued expenses and other current liabilities		4,584			1,370
Accrued expenses and other current liabilities – related parties		-			(142	)
Deferred revenue		(1,603	)		(1,972	)
Other noncurrent liabilities		-			112
Net cash provided by operating activities		65,360			27,959
Cash flows from investing activities
Collateralization of derivative instruments		1,237			(34	)
Purchase of marketable securities		(10,690	)		(19,322	)
Proceeds from the sale of marketable securities		35,718			10,268
Proceeds from the sale of fixed assets		20			-
Capital expenditures		(1,103	)		(1,686	)
Net cash provided by/(used in) investing activities		25,182			(10,774	)
Cash flows from financing activities
Minimum tax withholding on stock options exercised and awards vested		-			(8	)
Excess tax benefits associated with stock options and awards		-			(1	)
Payment of dividends		(5,248	)		(105,438	)
Net cash used in financing activities		(5,248	)		(105,447	)
Net change in cash and cash equivalents		85,294			(88,262	)
Cash and cash equivalents at beginning of period		114,627			199,272
Cash and cash equivalents at end of period	$	199,921		$	111,010

Cash paid for interest	$	-		$	-
Cash paid for income taxes	$	759		$	55

The accompanying notes are an integral part of these financial statements.

Notes to Consolidated Financial Statements of FutureFuel Corp.

(Dollars in thousands, except per share amounts)

(Unaudited)

1 )	NATURE OF OPERATIONS AND BASIS OF PRESENTATION

Organization

FutureFuel Corp. (“FutureFuel”), through its wholly-owned subsidiary, FutureFuel Chemical Company (“FutureFuel Chemical”), owns and operates a chemical production facility located on approximately 2,200 acres of land six miles southeast of Batesville in north central Arkansas fronting the White River (the “Batesville Plant”). FutureFuel Chemical manufactures diversified chemical products, biobased products comprised of biofuels, and biobased specialty chemical products. FutureFuel ~~Chemical~~’sChemical’s operations are reported in two segments: chemicals and biofuels.

The chemicals segment manufactures a diversified portfolio of chemical products that are sold to third party customers. The majority of the revenues from the chemicals segment are derived from the custom manufacturing of specialty chemicals for specific customers.

The biofuels business segment primarily produces and sells biodiesel. FutureFuel Chemical also sells petrodiesel in blends with the ~~company~~’scompany’s biodiesel and, from time to time, with no biodiesel added. Finally, FutureFuel Chemical is a shipper of refined petroleum products on common carrier pipelines and buys and sells petroleum products to maintain an active shipper status on these pipelines.

Basis of Presentation

The accompanying unaudited consolidated financial statements have been prepared by FutureFuel in accordance and consistent with the accounting policies stated in ~~FutureFuel’s 2016~~FutureFuel’s 2017 audited consolidated financial statements and should be read in conjunction with the ~~2016~~2017 audited consolidated financial statements of FutureFuel.

In the opinion of FutureFuel, all normal recurring adjustments necessary for a fair presentation have been included in the unaudited consolidated financial statements. The unaudited consolidated financial statements have been prepared in compliance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) accounting principles generally accepted in the United States (“GAAP”) for interim financial information and with instructions to Form 10-Q adopted by the Securities and Exchange Commission (“SEC”). Accordingly, the financial statements do not include all the information and footnotes required by GAAP for complete financial statements, and do include amounts that are based upon management estimates and judgments. Future actual results could differ from such current estimates. The unaudited consolidated financial statements include assets, liabilities, revenues, and expenses of FutureFuel and its wholly owned subsidiaries; namely, FutureFuel Chemical, FFC Grain, L.L.C., FutureFuel Warehouse Company, L.L.C., and Legacy Regional Transport, L.L.C. Intercompany transactions and balances have been eliminated in consolidation.

2 )	REINSTATEMENT OF THE BIODIESEL BLENDERS’ TAX CREDIT AND SMALL AGRI-BIODIESEL PRODUCER TAX CREDIT

The biodiesel Blenders’ Tax Credit (“BTC”) provides a $1.00 per gallon tax credit to the blender of biomass-based diesel with at least 0.1% petroleum-based diesel fuel. When in effect, FutureFuel is the blender of record and recognizes the credit as a reduction to cost of goods sold. The BTC expired on December 31, 2016 and was not reinstated for 2017 until it was signed into law as part of The Bipartisan Budget Act of 2018 passed by Congress on February 9, 2018. As this act was passed into law in 2018, FutureFuel recognized a net estimated pretax benefit from the reinstatement in the biofuels segment of $28,869 (a reduction in sales revenue of $13,559 for customer rebates (“BTC Rebates”) upon reinstatement and a reduction in cost of goods sold of $42,428). The gallons related to this credit were sold in the twelve months ended December 31, 2017.

As part of the law from which the BTC was reinstated, small agri-biodiesel producers with production capacity not in excess of 60 million gallons were eligible for an additional tax credit of $0.10 per gallon on the first 15 million gallons of agri-biodiesel sold (the “Small Agri-biodiesel Producer Tax Credit”). The benefit of the Small Agri-biodiesel Producer Tax Credit was recognized as a benefit in the tax provision in the three and six months ended June 30, 2018.

Neither the BTC nor the Small Agri-biodiesel Producer Tax Credit have been passed into law for 2018.

NotestoConsolidatedFinancialStatementsofFutureFuelCorp.

(Dollarsinthousands,exceptpershareamounts)

(Unaudited)

3 )

INVENTORY

The carrying values of inventory were as follows as of:

	June 30, 2017			December 31, 2016			June 30, 2018			December 31, 2017
At average cost (approximates current cost)
Finished goods	$	21,279		$	27,971		$	15,421		$	22,998
Work in process		2,046			1,913			1,549			1,735
Raw materials and supplies		21,630			25,127			40,671			27,143
		44,955			55,011			57,641			51,876
LIFO reserve		(8,066	)		(2,918	)		(10,120	)		(8,122	)
Total inventory	$	36,889		$	52,093		$	47,521		$	43,754

~~Notes~~to~~Consolidated~~~~Financial~~~~Statements~~of~~FutureFuel~~~~Corp.~~

~~(Dollars~~in~~thousands,~~~~except~~~~per~~~~share~~~~amounts)~~

~~(Unaudited)~~

~~FutureFuel recorded a lower~~Lower of costCost or ~~market~~Market ("LCM") ~~adjustment of $957 in the three and six months ended June 30, 2017. This LCM adjustment was~~adjustments are recorded as a decrease in inventory values and an increase in cost of goods sold. The inventory is relieved at the LCM adjusted cost basis when sold. There was no LCM adjustment in the three and six months ended June 30, 2018. For the three and six months ended June 30, ~~2016,~~2017, the LCM adjustment was ~~$1,895.~~$957.

34 )	DERIVATIVE INSTRUMENTS

FutureFuel is exposed to certain risks relating to its ongoing business operations. Commodity price risk is the primary risk managed by using derivative instruments. Regulated fixed price futures and option contracts are utilized to manage the price risk associated with future purchases of feedstock used in ~~FutureFuel~~’sFutureFuel’s biodiesel production along with physical feedstock and finished product inventories attributed to this process.

FutureFuel recognizes all derivative instruments as either assets or liabilities at fair value in its consolidated balance sheets. ~~FutureFuel~~’sFutureFuel’s derivative instruments do not qualify for hedge accounting under the specific guidelines of ASC 815-20-25, Derivativesand~~Hedging~~. Hedging. None of the derivative instruments are designated and accounted for as hedges primarily as a result of the extensive record keeping requirements.

The fair value of ~~FutureFuel~~’sFutureFuel’s derivative instruments is determined based on the closing prices of the derivative instruments on relevant commodity exchanges at the end of an accounting period. Realized gains and losses on derivative instruments and changes in fair value of the derivative instruments are recorded in the statements of operations as a component of cost of goods sold, and amounted to a loss of $3,109 and a gain of $524 ~~and a loss of $5,139~~ for the three months ended June 30, 2018 and 2017, respectively, and ~~2016, respectively,~~a loss of $3,271 and a gain of $1,803 ~~and a loss of $6,178~~ for the six months ended June 30, 2018 and 2017, ~~and 2016,~~ respectively.

The volumes and carrying values of ~~FutureFuel~~’sFutureFuel’s derivative instruments were as follows at:

	June 30, 2017					December 31, 2016					June 30, 2018					December 31, 2017
	Quantity (contracts) Short		Fair Value			Quantity (contracts) Short		Fair Value			Contract quantity Short		Fair Value			Contract quantity Short		Fair Value
Regulated options, included in other current assets		75	$	(520	)		-	$	-			100	$	(940	)		200	$	(2,428	)
Regulated fixed price future commitments, included in other current assets		35	$	(58	)		135	$	(258	)		171	$	71			-	$	-

The margin account maintained with a broker to collateralize these derivative instruments carried an account balance of ~~$793~~$1,423 and ~~$758~~$2,660 at June 30, ~~2017~~2018 and December 31, ~~2016,~~2017, respectively, and is classified as other current assets in the consolidated balance sheets. The carrying values of the margin account and of the derivative instruments are included net, in other current assets.

Notes to Consolidated Financial Statements of FutureFuel Corp.

(Dollars in thousands, except per share amounts)

(Unaudited)

45 )	MARKETABLE SECURITIES

At June 30, ~~2017~~2018 and December 31, ~~2016,~~2017, FutureFuel had investments in certain ~~preferred stock, trust~~debt securities (trust preferred securities and exchange traded debt ~~instruments,~~instruments) and in preferred stock and other equity instruments. These investments are classified as current assets in the consolidated balance sheets. FutureFuel has designated ~~these~~the debt securities as being available-for-sale. Accordingly, ~~they are~~debt securities were recorded at fair value, with the unrealized gains and losses, net of taxes, reported as a component of stockholders’ ~~equity.~~equity in the year ended December 31, 2017. For the six months ended, June 30, 2018, in accordance with ASC 321, the change in the fair value of equity securities was reported as (losses)/gains on marketable securities as a component of net income.

~~FutureFuel’s marketable~~FutureFuel’s available for sale debt securities were comprised of the following at June 30, ~~2017~~2018 and December 31, ~~2016:~~2017:

	June 30, 2018
	Adjusted Cost		Unrealized Gains		Unrealized Losses			Fair Value
Exchange traded debt	$	1,429	$	96	$	(9	)	$	1,516
Trust Preferred		3,147		97		-			3,244
Total debt securities	$	4,576	$	193	$	(9	)	$	4,760

	December 31, 2017
	Adjusted Cost		Unrealized Gains		Unrealized Losses			Fair Value
Exchange traded debt	$	1,702	$	158	$	-		$	1,860
Trust Preferred		3,147		114		-			3,261
Total debt securities	$	4,849	$	272	$	-		$	5,121

June 30, 2017

Adjusted Cost

Unrealized Gains

Unrealized Losses

Fair Value

Equity instruments
$ 45,596 $ 7,552 $ (318 ) $ 52,830
Preferred stock
55,927 4,360 (3 ) 60,284
Trust preferred securities
3,147 40 - 3,187
Exchange traded debt instruments
4,154 273 - 4,427
Total
$ 108,824 $ 12,225 $ (321 ) $ 120,728

December 31, 2016

Adjusted Cost

Unrealized Gains

Unrealized Losses

Fair Value

Equity instruments
$ 32,667 $ 5,549 $ (304 ) $ 37,912
Preferred stock
57,105 1,196 (698 ) 57,603
Trust preferred securities
3,147 - (9 ) 3,138
Exchange traded debt instruments
7,420 99 (26 ) 7,493
Total
$ 100,339 $ 6,844 $ (1,037 ) $ 106,146

The aggregate fair value of ~~instruments~~debt securities with unrealized losses totaled ~~$8,964~~ ~~and $31,126~~$297 at June 30, ~~2017~~2018, and the aggregate fair value of debt and equity securities with unrealized losses totaled $14,103 at December 31, ~~2016, respectively.~~2017. As of June 30, ~~2017 and~~2018, FutureFuel had investments in debt securities with a total value of $168 that were in an unrealized loss position for a greater than a 12-month period. As of December 31, ~~2016,~~2017, FutureFuel had no investments in ~~marketable~~debt and equity securities with a total value of $2,903 that were in an unrealized loss position for a greater than 12-month period. The unrealized loss position for those securities was $7 and $124, respectively. Those loss positions represented a minimal reduction for the securities and are expected to fully recover given changes in market value.

56 )	ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

Accrued expenses and other current liabilities, including those associated with related parties, consisted of the following at:

	June 30, 2017		December 31, 2016		June 30, 2018		December 31, 2017
Accrued employee liabilities	$	1,529	$	864	$	4,681	$	976
Accrued property, franchise, motor fuel and other taxes		1,978		1,428		1,948		1,387
Other		348		335		423		105
Total	$	3,855	$	2,627	$	7,052	$	2,468

Notes to Consolidated Financial Statements of FutureFuel Corp.

(Dollars in thousands, except per share amounts)

(Unaudited)

67 )	BORROWINGS

On April 16, 2015, FutureFuel, with FutureFuel Chemical as the borrower, and certain of ~~FutureFuel~~’sFutureFuel’s other subsidiaries, as guarantors, entered into a $150,000 secured and committed credit facility with the lenders party thereto, Regions Bank as administrative agent and collateral agent, and PNC Bank, N.A., as syndication agent. On May 25, 2016, FutureFuel increased the credit facility by $15,000. The credit facility consists of a five-year revolving credit facility in a dollar amount of up to $165,000, which includes a sublimit of $30,000 for letters of credit and $15,000 for swingline loans (collectively, the “Credit Facility”).

The interest rate floats at the following margins over LIBOR or base rate based upon the leverage ratio from time to time:

Consolidated Leverage Ratio			Adjusted LIBOR Rate Loans and Letter of Credit Fee		Base Rate Loans		Commitment Fee
< 1.00:1.0				1.25%		0.25%		0.15%
≥ 1.00:1.0	And	< 1.50:1.0		1.50%		0.50%		0.20%
≥ 1.50:1.0	And	< 2.00:1.0		1.75%		0.75%		0.25%
≥ 2.00:1.0	And	< 2.50:1.0		2.00%		1.00%		0.30%
≥ 2.50:1.0				2.25%		1.25%		0.35%

The terms of the Credit Facility contain certain covenants and conditions including a maximum consolidated leverage ratio, a minimum consolidated fixed charge coverage ratio, and a minimum liquidity requirement. FutureFuel was in compliance with such covenants as of June 30, ~~2017.~~2018.

There were no borrowings under this credit agreement at June 30, ~~2017~~2018 or December 31, ~~2016.~~2017.

78 )	PROVISION/(BENEFIT) FOR INCOME TAXES

The following table summarizes the provision/(benefit) for income taxes.

	Three months ended June 30,						Six months ended June 30,						Three months ended June 30,						Six months ended June 30,
	2017			2016			2017			2016			2018			2017			2018			2017
Provision/(benefit) for income taxes	$	48		$	(6,917	)	$	1,645		$	(8,789	)
(Benefit)/provision for income taxes													$	2,003		$	48		$	(1,676	)	$	1,645
Effective tax rate		5.4	%		(94.7	%)		28.0	%		(54.9	%)		24.9	%		5.4	%		(4.2%	)		28.0	%

The effective tax rate for the three months ~~and six months~~ended June 30, 2018 and 2017 reflects our expected tax rate on reported operating income before income tax. This three-month effective rate is expected to continue for the remainder of 2018.

The effective tax rate for the six months ended June 30, 2018 reflects our expected tax rate on reported operating income before income tax including the positive effect of the retroactive reinstatement of the 2017 BTC and Small Agri-biodiesel Producer Tax Credit. Our effective tax rate in the six months ended June 30, 2017 does not reflect the BTC and Small Agri-biodiesel Producer Tax Credit recognized in 2018 because these credits and incentives were retroactively extended through December 31, 2017 on February 9, 2018. This rate is not expected to continue for the remainder of 2018 as these credits only benefited the three months ended March 31, 2018 and six months ended June 30, ~~2017, reflects the elimination of certain tax credits and incentives which expired December 31, 2016 and were not in effect for 2017.~~ 2018.

Notes to Consolidated Financial Statements of FutureFuel Corp.

(Dollars in thousands, except per share amounts)

(Unaudited)

The effective tax rate for the three and six months ended June 30, 2016, reflects our expected tax rate on reported operating earnings before income tax. Our effective tax rate in the three and six months ended June 30, 2016, reflects the positive effect of the reinstatement of certain tax credits and incentives for 2016. In 2016, these tax credits and incentives formed a large proportion of FutureFuel’s net income. This increase in proportion combined with the income tax treatment of the credits and incentives reduced FutureFuel’s effective income tax rate in 2016. In addition, during the second quarter of 2016, FutureFuel booked a tax benefit related to the reversal of a state’s treatment of the taxability of the tax credits and incentives.

Unrecognized tax benefits totaled ~~$2,056 and $2,056~~$0 at June 30, ~~2017~~2018 and December 31, ~~2016, respectively.~~2017.

FutureFuel records interest and penalties, net, as a component of income tax expense. At June 30, ~~2017~~2018 and December 31, ~~2016,~~2017, FutureFuel recorded ~~$230 and $193, respectively,~~$0 in accruals for interest or tax penalties.

89 )	EARNINGS PER SHARE

~~We compute~~The Company computes earnings per share using the two-class method in accordance with ASC Topic No. 260, “Earnings per Share.” The two-class method is an allocation of earnings between the holders of common stock and a company’s participating security holders. ~~Our outstanding~~Outstanding non-vested shares of restricted stock contain non-forfeitable rights to dividends and, therefore, are considered participating securities for purposes of computing earnings per share pursuant to the two-class method. WeThe Company had no other participating securities at June 30, ~~2017~~2018 or ~~2016.~~2017.

Contingently issuable shares associated with outstanding service-based restricted stock units were not included in the earnings per share calculations for the three-month ~~and six month~~ periods ended June 30, ~~2017~~2018 or ~~2016~~2017 as the vesting conditions had not been satisfied.

Basic and diluted earnings per common share were computed as follows:

For the three months ended June 30,

For the six months ended June 30,

2017

2016

2017

2016

Numerator:

Net income
$ 834 $ 14,224 $ 4,230 $ 24,793
Less: distributed earnings allocated to non-vested stock
- (10 ) - (24 )
Less: undistributed earnings allocated to non-vested restricted stock
(1 ) (42 ) (10 ) (96 )
Numerator for basic earnings per share
$ 833 $ 14,172 $ 4,220 $ 24,673
Effect of dilutive securities:

Add: undistributed earnings allocated to non-vested restricted stock
1 42 10 96
Less: undistributed earnings reallocated to non-vested restricted stock
(1 ) (42 ) (10 ) (96 )
Numerator for diluted earnings per share
$ 833 $ 14,172 $ 4,220 $ 24,673
Denominator:

Weighted average shares outstanding – basic
�� 43,665,171 43,527,857 43,641,038 43,501,599
Effect of dilutive securities:

Stock options and other awards
10,517 902 8,362 5,910
Weighted average shares outstanding – diluted
43,675,688 43,528,759 43,649,400 43,507,509

Basic earnings per share
$ 0.02 $ 0.33 $ 0.10 $ 0.57
Diluted earnings per share
$ 0.02 $ 0.33 $ 0.10 $ 0.57

	For the three months ended June 30,						For the six months ended June 30,
	2018			2017			2018			2017
Numerator:
Net income	$	6,051		$	834		$	41,877		$	4,230
Less: distributed earnings allocated to non-vested stock		-			-			-			-
Less: undistributed earnings allocated to non-vested restricted stock		(3	)		(1	)		(24	)		(10	)
Numerator for basic earnings per share	$	6,048		$	833		$	41,853		$	4,220
Effect of dilutive securities:
Add: undistributed earnings allocated to non-vested restricted stock		3			1			24			10
Less: undistributed earnings reallocated to non-vested restricted stock		(3	)		(1	)		(24	)		(10	)
Numerator for diluted earnings per share	$	6,048		$	833		$	41,853		$	4,220
Denominator:
Weighted average shares outstanding – basic		43,716,726			43,665,171			43,716,698			43,641,038
Effect of dilutive securities:
Stock options and other awards		4,216			10,517			4,870			8,362
Weighted average shares outstanding – diluted		43,720,942			43,675,688			43,721,568			43,649,400

Basic earnings per share	$	0.14		$	0.02		$	0.96		$	0.10
Diluted earnings per share	$	0.14		$	0.02		$	0.96		$	0.10

Notes to Consolidated Financial Statements of FutureFuel Corp.

(Dollars in thousands, except per share amounts)

(Unaudited)

Certain options to purchase ~~FutureFuel~~’sFutureFuel’s common stock were not included in the computation of diluted earnings per share for the three and six months ended June 30, ~~2017~~2018 and ~~2016~~2017 because they were anti-dilutive in the periods. The weighted average number of options excluded on this basis was 030,000 and ~~15,000~~30,000 for the ~~three~~three-months and six-months ended June 30, ~~2017,~~2018, respectively. The weighted average number of options excluded on this basis was ~~110,000~~0 and ~~100,000~~15,000 for the three-months and six-months ended June 30, ~~2016,~~2017, respectively.

910 )

SEGMENT INFORMATION

FutureFuel has two reportable segments organized along similar product groups – chemicals and biofuels.

Chemicals

~~FutureFuel~~’sFutureFuel’s chemicals segment manufactures diversified chemical products that are sold externally to third party customers. This segment is comprised of two components: “custom manufacturing” (manufacturing chemicals for specific customers) and “performance chemicals” (multi-customer specialty chemicals).

Biofuels

~~FutureFuel~~’sFutureFuel’s biofuels business segment primarily manufactures and markets biodiesel. Biodiesel revenues are generated through the sale of biodiesel to customers through FutureFuel’s distribution network at the Batesville Plant, through distribution facilities available at leased oil storage facilities, and through a network of remotely located tanks. Biofuels revenues also include the sale of biodiesel blends with petrodiesel, petrodiesel with no biodiesel added, internally generated, separated ~~RINs,~~Renewable Identification Numbers (“RINs”), biodiesel production byproducts, and the purchase and sale of other petroleum products on common carrier pipelines. Bi~~odiesel~~Biodiesel selling prices and profitability can at times fluctuate based on the timing of unsold, internally generated RINs. FutureFuel does not allocate production costs to internally generated RINs, and, from time to time, can enter into sales of biodiesel on a “RINs-free” basis. Such method of selling results in FutureFuel maintaining possession of the applicable RINs from the sale. The benefit derived from the eventual sale of the RINs is not reflected in results of operations until such time as the RIN sale has been completed, which may lead to variability in reported operating results.

Summary of long-lived assets and revenues by geographic area

All of ~~FutureFuel~~’sFutureFuel’s long-lived assets are located in the United States.

Most of ~~FutureFuel~~’sFutureFuel’s sales are transacted with control and title passing at the time of shipment from the Batesville Plant, although some sales are transacted with control and title passing at the delivery point. While many of FutureFuel’s chemicals are utilized to manufacture products that are shipped, further processed, and/or consumed throughout the world, the chemical products, with limited exceptions, generally leave the United States only after ownership has transferred from FutureFuel to the customer. FutureFuel is rarely the exporter of record, never the importer of record into foreign countries, and is not always aware of the exact quantities of its products that are moved into foreign markets by its customers. FutureFuel does track the addresses of its customers for invoicing purposes and uses this address to determine whether a particular sale is within or outside the United States. FutureFuel’s revenues attributable to the United States and foreign countries (based upon the billing addresses of its customers) were as follows:

Three months ended June 30,

Six months ended June 30,

2017

2016

2017

2016

United States
$ 66,918 $ 67,209 $ 120,333 $ 113,215
All Foreign Countries
1,130 670 1,826 1,299
Total
$ 68,048 $ 67,879 $ 122,159 $ 114,514

	Three months ended June 30,				Six months ended June 30,
	2018		2017		2018		2017
United States	$	87,525	$	66,918	$	142,791	$	120,333
All Foreign Countries		811		1,130		1,292		1,826
Total	$	88,336	$	68,048	$	144,083	$	122,159

Revenues from a single foreign country during the three and ~~six-months~~six months ended June 30, ~~2017~~2018 and ~~2016~~2017 did not exceed 1% of total revenues.

Notes to Consolidated Financial Statements of FutureFuel Corp.

(Dollars in thousands, except per share amounts)

(Unaudited)

Summary of business by segment

	Three months ended June 30,						Six months ended June 30,						Three months ended June 30,						Six months ended June 30,
	2017			2016			2017			2016			2018			2017				2018			2017
Revenue
Custom chemicals	$	19,644		$	19,401		$	41,596		$	39,693		$	27,072		$	19,644			$	50,492		$	41,596
Performance chemicals		3,707			5,162			8,112			9,938			4,455			3,707				10,116			8,112
Chemicals revenue		23,351			24,563			49,708			49,631			31,527			23,351				60,608			49,708
Biofuels revenue		44,697			43,316			72,451			64,883		��	56,809			44,697				83,475			72,451
Total Revenue	$	68,048		$	67,879		$	122,159		$	114,514		$	88,336		$	68,048			$	144,083		$	122,159

Segment gross profit
Chemicals	$	5,332		$	6,297		$	12,341		$	14,869		$	8,016		$	5,332			$	15,572		$	12,341
Biofuels		(3,534	)		1,675			(4,413	)		4,156			255			(3,534	)			30,206			(4,413	)
Total gross profit		1,798			7,972			7,928			19,025			8,271			1,798				45,778			7,928
Corporate expenses		(2,424	)		(2,596	)		(5,079	)		(5,120	)		(2,431	)		(2,424	)			(5,371	)		(5,079	)
Income/(loss) before interest and taxes		(626	)		5,376			2,849			13,905
Income before interest and taxes														5,840			(626	)			40,407			2,849
Interest and other income		1,991			1,464			3,714			2,809			2,434			1,991				4,145			3,714
Interest and other expense		(483	)		467			(688	)		(710	)		(220	)		(483	)			(4,351	)		(688	)
(Provision)/benefit for income taxes		(48	)		6,917			(1,645	)		8,789			(2,003	)		(48	)			1,676			(1,645	)
Net income	$	834		$	14,224		$	4,230		$	24,793		$	6,051		$	834			$	41,877		$	4,230

Depreciation is allocated to segment costs of goods sold based on plant usage. The total assets and capital expenditures of FutureFuel have not been allocated to individual segments as large portions of these assets are shared to varying degrees by each segment, causing such an allocation to be of little value.

1011 )

FAIR VALUE MEASUREMENTS

Fair value is defined as the exit price, or the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants as of the measurement date. Fair value accounting pronouncements also include a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs market participants would use in valuing the asset or liability developed based on market data obtained from sources independent of FutureFuel. Unobservable inputs are inputs that reflect ~~FutureFuel~~’sFutureFuel’s assumptions about the factors market participants would use in valuing the asset or liability developed based upon the best information available in the circumstances. The hierarchy is broken down into three levels. Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2 inputs include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, and inputs (other than quoted prices) that are observable for the asset or liability, either directly or indirectly. Level 3 inputs are unobservable inputs for the asset or liability. Categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.

Notes to Consolidated Financial Statements of FutureFuel Corp.

(Dollars in thousands, except per share amounts)

(Unaudited)

The following tables provide information by level for assets and liabilities that are measured at fair value, on a recurring basis, at June 30, ~~2017~~2018 and December 31, ~~2016.~~2017.

	Asset (Liability)										Asset (Liability)
				Fair Value Measurements Using										Fair Value Measurements Using
	Fair Value at			Inputs Considered as:							Fair Value at			Inputs Considered as:
Description	June 30, 2017			Level 1			Level 2		Level 3		June 30, 2018			Level 1			Level 2		Level 3
Derivative instruments	$	(578	)	$	(578	)	$	-	$	-	$	(869	)	$	(869	)	$	-	$	-
Preferred stock, trust preferred securities, exchange traded debt instruments, and other equity instruments	$	120,728		$	120,728		$	-	$	-
Preferred stock, and other equity instruments											$	86,804		$	86,804		$	-	$	-
Trust preferred and exchange traded debt instruments											$	4,760		$	4,760		$	-	$	-

	Asset (Liability)										Asset (Liability)
				Fair Value Measurements Using										Fair Value Measurements Using
	Fair Value at			Inputs Considered as:							Fair Value at			Inputs Considered as:
Description	December 31, 2016			Level 1			Level 2		Level 3		December 31, 2017			Level 1			Level 2		Level 3
Derivative instruments	$	(258	)	$	(258	)	$	-	$	-	$	(2,428	)	$	(2,428	)	$	-	$	-
Preferred stock, trust preferred securities, exchange traded debt instruments, and other equity instruments	$	106,146		$	106,146		$	-	$	-
Preferred stock, and other equity instruments											$	115,578		$	115,578		$	-	$	-
Trust preferred and exchange traded debt instruments											$	5,121		$	5,121		$	-	$	-

1112 )

RECLASSIFICATIONS FROM ACCUMULATED OTHER COMPREHENSIVE INCOME:

The following tables summarize changes in accumulated other comprehensive income from unrealized gains and losses on available-for-sale securities in the three and six months ended June 30, ~~2017~~2018 and ~~2016.~~ 2017.

Changes in Accumulated Other Comprehensive Income Unrealized Gains and
Losses on Available-for-Sale Securities
For the three months ended June 30, 2017 and 2016
Changes in Accumulated Other Comprehensive Income From Unrealized							Changes in Accumulated Other Comprehensive Income From Unrealized
Gains and Losses on Available-for-Sale Securities							Gains and Losses on Available-for-Sale Securities
For the three months ended June 30, 2018 and 2017							For the three months ended June 30, 2018 and 2017
(net of tax)	(net of tax)						(net of tax)
		2017		2016				2018			2017
Balance at April 1		$	5,415	$	2,495			$	102		$	5,415
Other comprehensive income before reclassifications			1,799		1,275				43			1,799
Amounts reclassified from accumulated other comprehensive income			285		(398	)			-			285
Net current-period other comprehensive income			2,084		877				43			2,084
Balance at June 30		$	7,499	$	3,372			$	145		$	7,499


Changes in Accumulated Other Comprehensive Income Unrealized Gains and
Losses on Available-for-Sale Securities
For the six months ended June 30, 2017 and 2016
Changes in Accumulated Other Comprehensive Income From Unrealized							Changes in Accumulated Other Comprehensive Income From Unrealized
Gains and Losses on Available-for-Sale Securities							Gains and Losses on Available-for-Sale Securities
For the six months ended June 30, 2018 and 2017							For the six months ended June 30, 2018 and 2017
(net of tax)	(net of tax)						(net of tax)
		2017		2016				2018			2017
Balance at January 1		$	3,540	$	2,055
Balance at January 1^[1]								$	160		$	3,540
Other comprehensive income before reclassifications			3,589		1,054				(15	)		3,589
Amounts reclassified from accumulated other comprehensive income			370		263				-			370
Net current-period other comprehensive income			3,959		1,317				(15	)		3,959
Balance at June 30		$	7,499	$	3,372			$	145		$	7,499

[1] The beginning balance for 2018 was decreased $8,273 to reflect the impact of the adoption of ASU 2016-01. See Note 18 for additional information.

Notes to Consolidated Financial Statements of FutureFuel Corp.

(Dollars in thousands, except per share amounts)

(Unaudited)

The following tables summarize amounts reclassified from accumulated other comprehensive income in the three and six months ended June 30, ~~2017~~2018 and ~~2016:~~2017:

Reclassifications from Accumulated Other	Reclassifications from Accumulated Other								Reclassifications from Accumulated Other
Comprehensive Income for the three and six months ended	Comprehensive Income for the three and six months ended								Comprehensive Income for the three and six months ended
June 30, 2017 and 2016
June 30, 2018 and 2017									June 30, 2018 and 2017

		Three months ended June 30,								Three months ended June 30,
		2017			2016			Affected Line Item in Statement of Operations		2018		2017			Affected Line Item in Statement of Operations
Unrealized (losses)/gains on available-for-sale securities		$	(438	)	$	613		(Losses)/gains on marketable securities
Unrealized losses on available-for-sale debt securities										$	-	$	(438	)	Gain/(loss) on marketable securities
Total before tax			(438	)		613					-		(438	)
Tax provision/(benefit)			153			(215	)
Tax (provision)/benefit											-		153
Total reclassifications		$	(285	)	$	398				$	-	$	(285	)

		Six months ended June 30,								Six months ended June 30,
		2017			2016			Affected Line Item in Statement of Operations		2018		2017			Affected Line Item in Statement of Operations
Unrealized losses on available-for-sale securities		$	(569	)	$	(405	)	Losses on marketable securities
Unrealized losses on available-for-sale debt securities										$	-	$	(569	)	Gain/(loss) on marketable securities
Total before tax			(569	)		(405	)				-		(569	)
Tax provision			199			142
Tax benefit											-		199
Total reclassifications		$	(370	)	$	(263	)			$	-	$	(370	)

*Effective January 1, 2018, FutureFuel’s unrealized gains/(losses) on available-for-sale securities includes debt securities only in accordance with ASC 320 and ASC 321. The prior year was not restated under the modified retrospective approach in adoption of ASC 321. Please see Note 18 for further details on the adoption of this standard.

1213 )

LEGAL MATTERS

From time to time, FutureFuel and its operations are parties to, or targets of, lawsuits, claims, investigations, regulatory matters, and proceedings, which are being handled and defended in the ordinary course of business. While FutureFuel is unable to predict the outcomes of these matters, it does not believe, based upon currently available facts, that the ultimate resolution of any such pending matters will have a material adverse effect on its overall financial condition, results of operations, or cash flows.

1314 )

RELATED PARTY TRANSACTIONS

FutureFuel enters into transactions with companies affiliated with or controlled by a director and significant shareholder. Revenues, expenses, prepaid amounts, and unpaid amounts related to these transactions are captured in the accompanying consolidated financial statements as related party line items.

Related party revenues are the result of sales of biodiesel, petrodiesel, blends, other petroleum products, and other similar or related products to these related parties.

Related party cost of goods sold and distribution are the result of sales of biodiesel, petrodiesel, blends, and other petroleum products to these related parties along with the associated expense from the purchase of natural gas, storage and terminalling services, and income tax and consulting services by FutureFuel from these related parties.

Notes to Consolidated Financial Statements of FutureFuel Corp.

(Dollars in thousands, except per share amounts)

(Unaudited)

1415 )

INTANGIBLE ASSET

In April of 2015, FutureFuel acquired additional historical line space on a pipeline for $1,408. The acquired line space was recorded as an intangible asset with an indefinite life as there was no foreseeable limit on the time period over which it is expected to contribute to cash flows. The carrying value of the asset was $1,408 as of June 30, ~~2017~~2018 and December 31, ~~2016.~~2017. FutureFuel tests the intangible asset for impairment in accordance with ASC 350-30-35-18 through 35-20.

1516 )

RECENTLY ISSUED ACCOUNTING STATEMENTS

The following table provides a brief description of recent Accounting Standard Updates ("ASU") issued by the FASB:

Standard	Description	Effective Date	Effect on the Financial Statements or Other Significant Matters
In February 2016, the FASB issued ASU 2016-02, Leases.	The new guidance supersedes the lease guidance under FASB ASC Topic 840, Leases, resulting in the creation of FASB ASC Topic 842, Leases. The guidance requires a lessee to recognize in the statement of financial position a liability to make lease payments and a right-of-use asset representing its right to use the underlying asset for the lease term for both finance and operating leases.	Annual periods beginning after December 15, 2018. Early adoption is permitted.	The Company is currently evaluating its population of leases, and is continuing to assess all potential impacts of the standard, but currently believes the most significant impact relates to its accounting for logistics equipment. The Company anticipates recognition of additional assets and corresponding liabilities related to leases upon adoption. The Company plans to adopt the standard effective January 1, 2019.
In ~~May 2014,~~February 2018, the FASB issued ASU ~~2014-09, Revenue from Contracts with Customers. Since that date, the FASB has issued additional ASUs clarifying certain aspects of ASU 2014-09.~~2018-02, Income Statement-Reporting Comprehensive Income.	The ~~core principle of~~amendments in this ~~guidance is that an~~ ~~entity should recognize revenue~~Update allow a reclassification from accumulated other comprehensive income to ~~depict~~retained earnings for stranded tax effects resulting from the ~~transfer of promised goods or services~~Tax Cuts and Jobs Act passed by congress on December 22, 2017 and certain disclosures related to ~~customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for~~ those goods and services. To achieve the core principle, the guidance establishes the following five steps: 1) identify the contract(s) with a customer, 2) identify the performance obligation in the contract, 3) determine the transaction price, 4) allocate the transaction price to the performance obligations in the contract, and 5) recognize revenue when (or as) the entity satisfies a performance obligation. The guidance also details the accounting treatment for costs to obtain or fulfill a contract. Lastly, disclosure requirements have been enhanced to provide sufficient information to enable users of financial statements to understand the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers.stranded tax effects.	Annual periods beginning after December 15, ~~2017.~~ ~~Earlier~~2018. Early adoption ~~was permitted, but not before December 15, 2016.~~is permitted.	The Company is ~~in the process of~~currently evaluating the impact of this ~~guidance.~~ ~~This new guidance, will likely result in a change in the nature and extent of the related footnote disclosures.~~standard. The Company plans to adopt the standard on or before January 1, 2019.
In June 2018, the FASB issued ASU 2018-07, Improvements to Nonemployee Share-Based Payment Accounting.	This Update is part of the FASB Simplification Initiative. Under the new ~~guidance when~~standard, Topic 718 is expanded to include the nonemployee share-based payments. As a result, companies will no longer be required to value non-employee awards differently from employee awards. This means that companies will value all equity classified awards at their grant-date under ASC Topic 718 and forgo revaluing the award after that date as currently required under Subtopic 505-50.	Annual periods beginning after December 15, 2018. Early adoption is permitted.	The Company believes the adoption of the standard will have minimal impact on our financial statements. The Company plans to adopt the standard effective ~~and presently anticipates adopting on a modified retrospective basis to each prior reporting period presented with the election of applicable practical expedients.~~January 1, 2019.

NotestoConsolidatedFinancialStatementsofFutureFuelCorp.

(Dollarsinthousands,exceptpershareamounts)

(Unaudited)

17) REVENUE RECOGNITION

On January 1, 2018, FutureFuel adopted ASU 2014-09 Revenue Recognition (“Topic 606”). Under this standard, FutureFuel recognizes revenue when performance obligations of the sale are satisfied. FutureFuel sells to customers through master sales agreements or standalone purchase orders. The majority of FutureFuel's terms of sale have a single performance obligation to transfer products. Accordingly, FutureFuel recognizes revenue when control has been transferred to the customer, generally at the time of shipment or delivery of products. Under the previous revenue recognition accounting standard (“Topic 605”), FutureFuel recognized revenue upon the transfer of title and risk of loss, generally upon shipment or delivery of goods, although some revenue was recognized on a bill and hold basis.

A select number of FutureFuel custom chemical contracts within the chemical segment contain a material right as defined by Topic 606 as a result of upfront payments provided by customers. Each contract also has a performance obligation to transfer products with 30-day payment terms. FutureFuel recognizes revenue when the customer takes control of the inventory, either upon shipment or when the material is made available for pickup. FutureFuel has applied the renewal option approach in allocating the transaction price to these material rights and transfer of product. As a basis for allocating the transaction price to the material right and transfer of product, FutureFuel estimated the expected life of the product, the expected contractual volumes to be sold over that life, and the most likely expected sales price. Each estimate will be updated quarterly on a prospective basis. In applying the cumulative effect of Topic 606 as of January 1, 2018, FutureFuel recorded a gross reduction to opening retained earnings of $6,900 and a net of tax reduction of $5,178. Additionally, the adoption of Topic 606 resulted in one contract recognizing revenue on a bill and hold basis, whereas under Topic 605 it was recognized at point of shipment. The adoption of Topic 606 also increased short term deferred revenue $3,251 and long term deferred revenue $3,293 and reduced inventory $356 as of January 1, 2018.

The majority of our revenue is from short term contracts with revenue recognized when a single performance obligation to transfer product under the terms of a contract with a customer are satisfied. Accordingly, FutureFuel recognizes revenue when control is transferred to the customer, which is when products are considered to meet customer specification and title and risk of loss are transferred. This typically occurs at the time of shipment or delivery, however, for certain contracts, this occurs upon delivery of the material to a FutureFuel storage location, ready for customer pickup and separated from other FutureFuel inventory. Revenue is measured as the amount of consideration FutureFuel expects to receive in exchange for transferring products and is generally based upon a negotiated price. FutureFuel sells its products directly to customers generally under agreements with payment terms of 30 to 75 days for chemical segment customers and 3 to 10 days for biofuel segment customers. For these short term contracts, there was no material change in recognizing revenue under Topic 606 and Topic 605.

Contract Assets and Liabilities:

Contract assets consist of unbilled amounts typically resulting from revenue recognized through bill and hold arrangements. The contract assets are recorded as accounts receivable on the consolidated balance sheet. Contract liabilities consist of advance payments related to material rights. These amounts were historically recorded as deferred revenue which primarily related to upfront capital payments. The contract liabilities are recorded as deferred revenue in the consolidated balance sheets and are reduced as FutureFuel transfers product to the customer under the renewal option approach.

NotestoConsolidatedFinancialStatementsofFutureFuelCorp.

(Dollarsinthousands,exceptpershareamounts)

(Unaudited)

These contract assets and liabilities are reported on the consolidated balance sheets on a contract-by-contract basis at the end of each reporting period.

The following table reflects the changes in FutureFuel’s contract assets and contract liabilities for the three and six months ended June 30, 2018. There were no contract assets recognized under Topic 605:

Contract assets - short-term (included in accounts receivable)
	Three months ended June 30, 2018
Beginning balance at March 31, 2018	$	651
Additions		1,110
Reductions		(651	)
Ending balance at June 30, 2018	$	1,110
	Six months ended June 30, 2018
Beginning balance at January 1, 2018	$	505
Additions		1,761
Reductions		(1,156	)
Ending balance at June 30, 2018	$	1,110

	As Reported			Under Prior Standard
Contract Liabilities	Topic 606			Topic 605			Change
Current
Beginning balance at March 31, 2018	$	5,650		$	2,529		$	3,121
Revenue recognized for the three months ended June 30, 2018		(165	)		(24	)		(141	)
Ending balance at June 30, 2018		5,485			2,505			2,980

Beginning balance at January 1, 2018		5,780			2,529			3,251
Revenue recognized for the six months ended June 30, 2018		(295	)		(24	)		(271	)
Ending balance at June 30, 2018	$	5,485		$	2,505		$	2,980

Long term
Beginning balance at March 31, 2018	$	13,843		$	11,308		$	2,535
Additions		458			458			-
Revenue recognized for the three months ended June 30, 2018		(1,631	)		(1,173	)		(458	)
Ending balance at June 30, 2018		12,670			10,593			2,077

Beginning balance at January 1, 2018		15,233			11,940			3,293
Additions		458			458			-
Revenue recognized for the six months ended June 30, 2018		(3,021	)		(1,805	)		(1,216	)
Ending balance at June 30, 2018	$	12,670		$	10,593		$	2,077

Transaction price allocated to the remaining performance obligations

As of June 30, 2018, approximately $18,155 of revenue is expected to be recognized from remaining performance obligations. FutureFuel expects to recognize this revenue ratably over expected sales over the expected term of its long-term contracts which range from one to five years. Approximately 30% of this revenue is expected to be recognized over the next 12 months, and 70% is expected to be recognized between one and 5 years. These amounts are subject to change based upon changes in the estimated contract life and estimated quantities to be sold over the contract life.

NotestoConsolidatedFinancialStatementsofFutureFuelCorp.

(Dollarsinthousands,exceptpershareamounts)

(Unaudited)

We applied the practical expedient in ASC 606-10-50-14 and have excluded the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less; and (ii) contracts for which we recognize revenue at the amount to which we have the right to invoice for services performed.

Disaggregation of revenue – contractual and non-contractual

	Three months ended June 30,				Six months ended June 30,
	2018		2017^(a)		2018			2017^(a)
Contract revenue from customers with > 1 year arrangements	$	17,908	$	11,973	$	33,158		$	25,927
Contract revenue from customers with < 1 year arrangement		70,373		56,007		124,414			96,122
Revenue from non-contractual arrangements		55		68		110			110
BTC rebate		-				(13,599	)
Total revenue	$	88,336	$	68,048	$	144,083		$	122,159

Timing of Revenue

	Three months ended June 30,				Six months ended June 30,
	2018		2017^(a)		2018		2017^(a)
Bill and hold revenue	$	13,373	$	3,460	$	20,894	$	7,958
Non-bill and hold revenue		74,963		64,588		123,189		114,201
Total revenue	$	88,336	$	68,048	$	144,083	$	122,159

(a)

Prior periods have not been adjusted under the modified retrospective method for Topic 606.

For both long term and short term contracts, FutureFuel has elected to account for shipping and handling as activities to fulfill the promise to transfer the good. As such, shipping and handling fees billed to customers in a sales transaction are recorded in net sales and shipping and handling costs incurred are recorded in cost of goods sold and distribution. FutureFuel has elected to exclude from net sales any taxes which it collects concurrent with revenue-producing activities. These accounting policy elections are consistent with the manner in which FutureFuel historically recorded shipping and handling fees and taxes.

The following table summarizes the impacts of Topic 606 adoption on the Company’s consolidated statement of operations and comprehensive income for the three and six months ended June 30, 2018.

	Three months ended June 30, 2018
	Balances Prior to Adoption of Topic 606		Adjustments		As Reported

Revenue	$	86,595	$	1,058	$	87,653
Cost of goods sold		72,915		303		73,218
Gross profit		7,516		755		8,271
Income from operations		5,085		755		5,840
Income before income taxes		7,299		755		8,054
(Benefit)/provision for income taxes		1,814		189		2,003
Net income	$	5,485	$	566	$	6,051
Basic earnings per share	$	0.13	$	0.01	$	0.14
Diluted earnings per share	$	0.13	$	0.01	$	0.14
Comprehensive income	$	5,528	$	566	$	6,094

NotestoConsolidatedFinancialStatementsofFutureFuelCorp.

(Dollarsinthousands,exceptpershareamounts)

(Unaudited)

	Six months ended June 30, 2018
	Balances Prior to Adoption of Topic 606			Adjustments		As Reported

Revenue	$	139,999		$	2,597	$	142,596
Cost of goods sold		84,944			413		85,357
Gross profit		43,594			2,184		45,778
Income from operations		38,223			2,184		40,407
Income before income taxes		38,017			2,184		40,201
(Benefit)/provision for income taxes		(2,165	)		489		(1,676	)
Net income	$	40,182		$	1,695	$	41,877
Basic earnings per share	$	0.92		$	0.04	$	0.96
Diluted earnings per share	$	0.92		$	0.04	$	0.96
Comprehensive income	$	40,167		$	1,695	$	41,862

The following table summarizes the impacts of Topic 606 adoption on the Company’s consolidated balance sheet which has been adjusted for the adoption of Topic 606 as of June 30, 2018.

	Balances Prior
	to Adoption of
	Topic 606		Adjustments			As Reported
Accounts receivable	$	21,280	$	1,110		$	22,390
Inventory		48,289		(768	)		47,521
Income tax receivable		3,513		(32	)		3,481
Total current assets		366,642		310			366,952
Total assets		477,101		310			477,411
Deferred revenue - short term		2,712		2,980			5,692
Total current liabilities		50,507		2,980			53,487
Deferred revenue - long term		15,065		2,077			17,142
Noncurrent deferred income tax liability		18,424		(1,264	)		17,160
Total noncurrent liabilities		34,618		813			35,431
Total liabilities		85,125		3,793			88,918
Retained earnings		109,649		(3,483	)		106,166
Total stockholders' equity		391,976		(3,483	)		388,493
Total liabilities and stockholders' equity	$	477,101	$	310		$	477,411

The following table summarizes the impacts of our adoption of Topic 606 on the Company’s consolidated statement of cash flows for the six months ended June 30, 2018:

	Balances Prior
	to Adoption of						As Reported
	Topic 606			Adjustments			or Restated
Change in net income	$	40,182		$	1,695		$	41,877
Benefit for deferred income taxes		(2,621	)		(1,264	)		(3,885	)
Changes in operating assets and liabilities:
Accounts receivables		693			(1,110	)		(417	)
Inventory		(4,528	)		768			(3,760	)
Income tax receivable		3,424			32			3,456
Deferred revenue		(1,482	)		(121	)		(1,603	)
Net cash provided by operating activities	$	65,360		$	-		$	65,360

NotestoConsolidatedFinancialStatementsofFutureFuelCorp.

(Dollarsinthousands,exceptpershareamounts)

(Unaudited)

18 ) CHANGE IN ACCOUNTING PRINCIPLE AND ERROR CORRECTIONS

In January 2016, the FASB issued ASU 2016-01, Financial Instruments - Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities. One provision of this update requires that equity investments, except those accounted for under the equity method or resulting in consolidation, be measured at fair value and changes in fair value recognized in net income. The provisions of this update are recognized as a cumulative-effect adjustment to the balance sheet as of the beginning of the fiscal year of adoption. For public entities, this guidance was effective for years beginning after December 15, 2017, including interim periods within those years.

The new accounting standard related to the recognition and measurement of financial assets and liabilities makes the following changes to prior guidance and requires:

●

certain equity investments to be measured at fair value with changes in fair value now recognized in net income. However, equity investments that do not have readily determinable fair values may be measured at cost minus

impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer;

●

a qualitative assessment of equity investments without readily determinable fair values to identify impairment; and

●

separate presentation of financial assets and financial liabilities by measurement category and form of financial

asset on the balance sheet or in the accompanying notes to the financial statements.

We adopted the new accounting standard utilizing the modified retrospective method, and, therefore, no adjustments were made to amounts in our prior period financial statements. We recorded the cumulative effect of adopting the standard as an adjustment to increase the opening balance of retained earnings by $13,139 on a pre-tax basis ($8,273 after-tax) related to the net impact of unrealized gains and losses primarily on equity securities and preferred stock.

	Three months ended June 30,						Six months ended June 30,
	2018				2017*			2018			2017*
Net gains/(losses) recognized on equity securities	$	281		$	(438	)	$	(4,088	)	$	(569	)
Less: net gains/(losses) recognized during the period on equity securities sold during the period		663			(438	)		2,324			(569	)
Unrealized gains/(losses) during the reporting period on equity securities held at the reporting date	$	(382	)	$	-		$	(6,412	)	$	-

*Prior periods have not been adjusted under the modified retrospective method for Topic 321.

For the three months ended March 31, 2018, the Company had failed to adopt the standard and presented the unrealized loss on equity investments as a change in accumulated other comprehensive income within the equity section of the Consolidated Balance Sheets. Within the six-month period, the Company corrected the first quarter of 2018, by recording $5,744 of unrealized pre-tax losses ($4,528, net of tax) on equity securities from accumulated other comprehensive income to net income. The restated balances ended March 31, 2018 were as follows:

NotestoConsolidatedFinancialStatementsofFutureFuelCorp.

(Dollarsinthousands,exceptpershareamounts)

(Unaudited)

					Adjustment
					for Adoption
Balance sheet impact to previously reported period	As Reported			of Topic 321				As Recast
Liabilities and stockholders' equity
Additional other comprehensive income	$	3,847			$	(3,745	)	$	102
Retained earnings		96,371				3,745			100,116

Income statement impact to previously reported period
Gain/(loss) on marketable securities	$	1,375			$	(5,744	)	$	(4,369	)
Income before income taxes		37,891				(5,744	)		32,147
(Benefit)/provision for income taxes		(2,463	)			(1,216	)		(3,679	)
Net income		40,354				(4,528	)		35,826
Earnings per common share, basic and diluted:		0.92				(0.10	)		0.82
Other comprehensive income from unrealized net gain on available for sale securities		(5,818	)			5,744			(74	)
Income tax effect		1,232				(1,216	)		16
Total unrealized (loss)/gain, net of tax		(4,586	)			4,528			(58	)

Cash flow impact provided by operating activities
Net income	$	40,354			$	(4,528	)	$	35,826
Benefit for deferred income taxes		(2,388	)			(1,216	)		(3,604	)
Change in fair value of equity securities		-				6,030			6,030
Other than temporary impairment of marketable securities		286				(286	)		-

With adoption of the Topic 321, the prior period change in net gains/(losses) was as follows:

	Three months ended March 31,
	2018			2017
Net losses recognized on equity securities	$	(4,369	)	$	(131	)
Less: net gains recognized during the period on equity securities sold during the period		1,661			(131	)
Unrealized losses during the reporting period on equity securities held at the reporting date	$	(6,030	)	$	-

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

All dollar amounts expressed as numbers in this M D&A are in thousands (except per share amounts).

Certain tables may not add due to rounding.

The following ~~Management~~’sManagement’s Discussion and Analysis of Financial Condition and Results of Operations should be read together with our consolidated financial statements, including the notes thereto, set forth herein. This discussion contains forward-looking statements that reflect our current views with respect to future events and financial performance. Actual results may differ materially from those anticipated in these forward-looking statements. See “Forward Looking Information” below for additional discussion regarding risks associated with forward-looking statements.

Overview

Our company is managed and reported in two reporting segments: chemicals segment and biofuels segment. Within the chemicals segment are two product groupings: custom chemicals and performance chemicals. The custom product group is comprised of specialty chemicals manufactured for a single customer whereas the performance product group is comprised of chemicals manufactured for multiple customers. The biofuels segment is comprised of one product group. Management believes that the diversity of each segment strengthens the company in the ability to utilize resources and is committed to growing each segment.

Summary of Financial Results

Set forth below is a summary of certain consolidated financial information for the periods indicated.

	Three months ended June 30,											Three months ended June 30,
						Dollar			%								Dollar			%
	2017			2016		Change			Change			2018		2017			Change			Change
Revenues	$	68,048		$	67,879	$	169			0.2%		$	88,336	$	68,048		$	20,288			29.8	%
Income/(loss) from operations	$	(626	)	$	5,376	$	(6,002	)		(111.6%	)
Income from operations												$	5,840	$	(626	)	$	6,466			1,032.9	%
Net income	$	834		$	14,224	$	(13,390	)		(94.1%	)	$	6,051	$	834		$	5,217			625.5	%
Earnings per common share:
Basic	$	0.02		$	0.33	$	(0.31	)		(93.9%	)	$	0.14	$	0.02		$	0.12			600.0	%
Diluted	$	0.02		$	0.33	$	(0.31	)		(93.9%	)	$	0.14	$	0.02		$	0.12			600.0	%
Capital expenditures and intangibles (net of customer reimbursements and regulatory grants)	$	715		$	1,357	$	(642	)		(47.3%	)	$	536	$	715		$	(179	)		(25.0	%)
Adjusted EBITDA	$	2,079		$	13,581	$	(11,502	)		(84.7%	)	$	11,667	$	2,079		$	9,588			461.3	%

	Six months ended June 30,											Six months ended June 30,
						Dollar			%								Dollar			%
	2017			2016		Change			Change			2018		2017			Change			Change
Revenues	$	122,159		$	114,514	$	7,645			6.7%		$	144,083	$	122,159		$	21,924			17.9	%
Income from operations	$	2,849		$	13,905	$	(11,056	)		(79.5%	)	$	40,407	$	2,849		$	37,558			1,318.3	%
Net income	$	4,230		$	24,793	$	(20,563	)		(82.9%	)	$	41,877	$	4,230		$	37,647			890.0	%
Earnings per common share:
Basic	$	0.10		$	0.57	$	(0.47	)		(82.5%	)	$	0.96	$	0.10		$	0.86			860.0	%
Diluted	$	0.10		$	0.57	$	(0.47	)		(82.5%	)	$	0.96	$	0.10		$	0.86			860.0	%
Capital expenditures and intangibles (net of customer reimbursements and regulatory grants)	$	1,557		$	2,135	$	(578	)		(27.1%	)	$	897	$	1,557		$	(660	)		(42.4	%)
Adjusted EBITDA	$	7,648		$	26,283	$	(18,635	)		(70.9%	)	$	49,264	$	7,648		$	41,616			544.1	%

We use adjusted EBITDA as a key operating metric to measure both performance and liquidity. Adjusted EBITDA is a non-GAAP financial measure. Adjusted EBITDA is not a substitute for operating income, net income, or cash flow from operating activities (each as determined in accordance with GAAP) as a measure of performance or liquidity. Adjusted EBITDA has limitations as an analytical tool, and should not be considered in isolation or as a substitute for analysis of results as reported under GAAP. We define adjusted EBITDA as net income before interest, income taxes, depreciation, and amortization expenses, excluding, when applicable, non-cash stock-based compensation expenses, public offering expenses, acquisition-related transaction costs, purchase accounting adjustments, losses on disposal of property and equipment, gains or losses on derivative instruments, and other non-operating income or expenses. Information relating to adjusted EBITDA is provided so that investors have the same data that we employ in assessing the overall operation and liquidity of our business. Our calculation of adjusted EBITDA may be different from similarly titled measures used by other companies; therefore, the results of our calculation are not necessarily comparable to the results of other companies.

Adjusted EBITDA allows our chief operating decision makers to assess the performance and liquidity of our business on a consolidated basis to assess the ability of our operating segments to produce operating cash flow to fund working capital needs, to fund capital expenditures and to pay dividends. In particular, our management believes that adjusted EBITDA permits a comparative assessment of our operating performance and liquidity, relative to a performance and liquidity based on GAAP results, while isolating the effects of certain items, including depreciation and amortization, which may vary among our operating segments without any correlation to their underlying operating performance, non-cash stock-based compensation expense, which is a non-cash expense that varies widely among similar companies, and gains and losses on derivative instruments, which can cause net income to appear volatile from period to period relative to the sale of the underlying physical product.

We enter into commodity derivative instruments primarily to protect our operations from downward movements in commodity prices, and to provide greater certainty of cash flows associated with sales of our commodities. We enter into hedges, and we utilize mark-to-market accounting to account for these instruments. Thus, our results in any given period can be impacted, and sometimes significantly, by changes in market prices relative to our contract price along with the timing of the valuation change in the derivative instruments relative to the sale of biofuel. We include this item as an adjustment as we believe it provides a relevant indicator of the underlying performance of our business in a given period.

The following table reconciles adjusted EBITDA with net income, the most directly comparable GAAP performance financial measure.

	Three months ended June 30,						Six months ended June 30,						Three months ended June 30,						Six months ended June 30,
	2017			2016⁽¹⁾			2017			2016⁽¹⁾			2018			2017			2018			2017
Adjusted EBITDA	$	2,079		$	13,581		$	7,648		$	26,283		$	11,667		$	2,079		$	49,264		$	7,648
Depreciation		(2,912	)		(2,671	)		(5,808	)		(5,329	)		(2,756	)		(2,912	)		(5,512	)		(5,808	)
Non-cash stock-based compensation		(273	)		(477	)		(750	)		(954	)		(107	)		(273	)		(214	)		(750	)
Interest and dividend income		1,991			1,464			3,714			2,809			2,153			1,991			4,145			3,714
Interest expense		(43	)		(42	)		(86	)		(85	)
Non-cash interest expense														(43	)		(43	)		(86	)		(86	)
Losses on disposal of property and equipment		(46	)		(22	)		(77	)		(137	)		(32	)		(46	)		(37	)		(77	)
Gains/(losses) on derivative instruments		524			(5,139	)		1,803			(6,178	)
(Losses)/gains on derivative instruments														(3,109	)		524			(3,271	)		1,803
Gains/(losses) on marketable securities		(438	)		613			(569	)		(405	)		281			(438	)		(4,088	)		(569	)
Income tax (expense)/benefit		(48	)		6,917			(1,645	)		8,789
Income tax (provision)/benefit														(2,003	)		(48	)		1,676			(1,645	)
Net income	$	834		$	14,224		$	4,230		$	24,793		$	6,051		$	834		$	41,877		$	4,230

The following table reconciles adjusted EBITDA with cash flows from operations, the most directly comparable GAAP liquidity financial measure.

	Six months ended June 30,						Six months ended June 30,
	2017			2016⁽¹⁾			2018			2017
Adjusted EBITDA	$	7,648		$	26,283		$	49,264		$	7,648
Provision for deferred income taxes		(1,763	)		(4,969	)
Benefit for deferred income taxes								(3,885	)		(1,763	)
Impairment of fixed assets		9			178			171			9
Interest and dividend income		3,714			2,809			4,145			3,714
Income tax (expense)/benefit		(1,645	)		8,789
Income tax benefit/(expense)								1,676			(1,645	)
Gains/(losses) on derivative instruments		1,803			(6,178	)		(3,271	)		1,803
Change in fair value of derivative instruments		318			4,869			(1,559	)		318
Changes in operating assets and liabilities, net		17,876			14,310			18,819			17,876
Other		(1	)		(63	)		-			(1	)
Net cash provided by operating activities	$	27,959		$	46,028		$	65,360		$	27,959

~~(1) Prior year adjusted EBITDA reconciliations have been modified to be consistent with current year presentations.~~

Results of Operations

Consolidated

	Three months ended June 30,										Six months ended June 30,										Three months ended June 30,									Six months ended June 30,
					Change										Change										Change									Change
	2017		2016		Amount			%			2017		2016		Amount			%			2018		2017		Amount		%			2018		2017		Amount		%

Revenues	$	68,048	$	67,879	$	169			0.2	%	$	122,159	$	114,514	$	7,645			6.7	%	$	88,336	$	68,048	$	20,288		29.8	%	$	144,083	$	122,159	$	21,924		17.9	%
Volume/product mix effect					$	(11,693	)		(17.2	%)					$	(16,510	)		(14.4	%)					$	14,739		21.7	%					$	21,342		17.5	%
Price effect					$	11,862			17.5	%					$	24,155			21.1	%					$	5,549		8.2	%					$	582		0.5	%

Gross profit	$	1,798	$	7,972	$	(6,174	)		(77.4	%)	$	7,928	$	19,025	$	(11,097	)		(58.3	%)	$	8,271	$	1,798	$	6,473		360.0	%	$	45,778	$	7,928	$	37,850		477.4	%

Consolidated sales revenue in the three and six months ended June 30, ~~2017~~2018 increased ~~$169~~$20,288 and ~~$7,645~~$21,924, compared to the three and six months ended June 30, ~~2016. This increase~~2017. The three-month period increased $8,111 from higher chemical sales volumes from strong demand in the agrochemical and energy markets; $6,628 from stronger biodiesel sales volumes, and $5,484 from higher biofuel sales prices. The six-month period increased $9,472 from higher chemical sales volumes, $1,428 from higher chemical sales prices primarily ~~resulted~~from the adoption of ASC 606, and in part from higher prices ~~in the biofuel segment. However,~~indexed to raw materials. Also benefiting sales revenue for the ~~three months ended June 30, 2017, higher prices in the biofuel segment were mostly offset by reduced biofuel~~six-month period was stronger biodiesel sales volumes ~~driven in part by the expiration~~of $11,870 which was net of the ~~federal~~retroactive reinstatement of the 2017 blenders’ tax credit ~~(“BTC”). Also, partially offsetting the increase in the three months ended June 30, 2017, chemical segment revenue declined 5%~~(BTC) passed into law on February 9, 2018, presented as ~~compared to the prior year period.~~ a price effect. Please see Note 2 for additional discussion.

Gross profit in the three and six months ended June 30, ~~2017 decreased~~ ~~$6,174~~2018 increased $6,473 and ~~$11,097,~~$37,850 compared to the three months and six months ended June 30, ~~2016. In~~2017. The three-month increase was driven by higher volumes in the agrochemical and energy markets and stronger margins on higher volumes in the biofuel segment. The six-month increase was primarily from the biofuel segment ~~this decrease largely resulted from~~as the ~~absence~~result of the BTC which expired on December 31, 2016 and ~~from losses incurred~~was retroactively reinstated for 2017 (but, not beyond 2017) on ~~common carrier pipelines. We also experienced a reduction~~February 9, 2018 resulting in ~~chemical~~the benefit being recognized in 2018. Also benefiting gross profit was increased sales ~~volume for~~volumes in both the ~~three months ended June 30, 2017 as compared to the prior year period.~~ chemicals and biofuels segments.

~~Another significant impact to the reduction in gross~~Gross profit was favorably impacted in the three and six months ended June 30, ~~2017~~2018, as compared to the prior year ~~periods was~~period, by the adjustment ~~in the carrying value of our inventory as~~ determined utilizing the LIFO method of inventory accounting. This adjustment reduced gross profit $3,271 and $5,148 in the three and six months ended June 30, 2017 and decreased gross profit $3,319 in the three months ended June 30, 2016 and increased gross profit $2,257 in the six months ended June 30, 2016.

~~Partially offsetting these declines was the change in the unrealized and realized activity in derivative instruments.~~ In the three and six months ended June 30, 2017, the gain was $524 and $1,803, respectively as compared to a loss in the three and six months ended June 30, 2016 of $5,139 and $6,178. In addition, the change in the lower of cost or market adjustment in the three and six months ended June 30, 2017 was a benefit as compared to the prior year periods. In the three and six months ended June 30, 2017, the lower of cost or market adjustment was $957 in comparison to $1,895 in the three and six months ended June 30, 2016

~~Operating~~~~Expenses~~

~~Operating expenses decreased~~ $172 and $41 in the three and six months ended June 30, 2017, respectively, as compared to the three and six months ended June 30, 2016. This reduction in both periods was from lower compensation cost partially offset by higher research and development expense.

~~Provision/(Benefit)~~~~for Income~~~~Taxes~~

The effective tax rate for the three and six months ended June 30, 2017, reflects our expected tax rate on reported operating income before income tax. Our effective tax rate in the three and six months ended June 30, 2017, reflects the elimination of cer~~tain tax credits and incentives for 2017.~~

The effective tax rate for the three and six months ended June 30, 2016, reflects our expected tax rate on reported operating income earnings before income tax. Our effective tax rate in the three and six months ~~ended June 30, 2016, reflects the positive effect of the reinstatement of the certain tax credits and incentives for 2016.~~ ~~In addition, during the second quarter of 2016, FutureFuel booked a tax benefit related to the reversal of a state’s treatment of the taxability of the tax credits and incentives.~~

~~Unrecognized tax benefits totaled $2,056~~ ~~at June 30, 2017 and December 31, 2016.~~

~~Net~~~~Income~~

~~Net income for the three and six months~~ ended June 30, 2017 decreased $13,390 and $20,563, respectively, as compared to the same periods in 2016. The decrease resulted from the lack of the benefit of tax credits and incentives in effect in the three and six months ended June 30, 2016 which was not in effect in the three and six months ended June 30, 2017. Additionally, the adjustments in the carrying value of our inventory as determined utilizing the LIFO method of inventory ~~accounting negatively impacted net income~~accounting. The change in this adjustment increased gross profit $943 and $3,150 in the three and six months ended June 30, 2018 as compared to the three and six months ended June 30, 2017. This change in LIFO resulted in a lower of cost or market adjustment of $957 in the three and six months ended June 30, 2017 and ~~in comparison, negatively impacted net income~~no such adjustment was necessary in the three months ended June 30, ~~2016~~2018. Please see Note 3 for additional discussion.

Gross profit was negatively impacted by the change in the unrealized and ~~benefited net income~~realized activity in derivative instruments with a loss of $3,109 and $3,271 in the three and six months ended June 30, ~~2016.~~2018, as compared to a gain of $524 and $1,803, in the prior year period.

~~Chemicals~~Operating ~~Segment~~Expenses

Three months ended June 30,

Six months ended June 30,

Change

Change

2017

2016

Amount

%

2017

2016

Amount

%

Revenues
$ 23,351 $ 24,563 $ (1,212 ) (4.9 %) $ 49,708 $ 49,631 $ 77 0.2 %
Volume/product mix effect
$ (1,172 ) (4.8 %) $ (163 ) (0.3 %)
Price effect
$ (40 ) (0.2 %) $ 240 0.5 %

Gross profit
$ 5,332 $ 6,297 $ (965 ) (15.3 %) $ 12,341 $ 14,869 $ (2,528 ) (17.0 %)

~~Sales revenue~~Operating expenses increased $7 and $292 in the three months ended June 30, 2017 decreased by $1,212 compared to the three months ended June 30, 2016. Sales revenue for our custom chemicals (unique chemicals produced for specific customers) for the three months ended June 30, 2017 ~~totaled $19,644, an increase of $243 from the comparable period in 2016. This increase was primarily attributed to increased sales volumes in the agrochemical~~ and energy markets and accelerated amortization of deferred revenue from headwinds of global competition partially offset by the reduced price and volume of the laundry detergent additive. Performance chemicals (comprised of multi-customer products which are sold based on specification) sales revenues were $3,707 in the three months ended June 30, 2017, a decrease of $1,455 from the three months ended June 30, 2016. This decrease was primarily from a temporary reduction in sales volumes of a monomer product related to equipment modifications at one of our key customer’s facilities.

~~Sales revenue in th~~e six months ended June 30, 2017 increased $77 compared to the three months ended June 30, 2016. This increase was primarily attributed to increased sales volume in the agrochemical and energy markets and increased amortization of deferred revenue mostly offset by the reduced price and volume of the laundry detergent additive. Performance chemical sales revenue were down $1,826 to $8,112. This decrease was primarily from reduced sales volumes of a polymer modifier product and glycerin products.

~~Gross profit for the chemicals segment for the three and six months ended~~ ~~June 30, 2017 decreased by $965 and $2,528 when~~2018, respectively, as compared to the three and six months ended June 30, ~~2016. Gross profits~~2017. This increase was primarily from an increase in compensation.

Provision/(Benefit)for IncomeTaxes

The effective tax rate for the three months ended June 30, 2018 and 2017 reflects our expected tax rate on reported operating income before income tax. This three-month effective rate is expected to continue for the remainder of 2018.

The effective tax rate for the six months ended June 30, 2018 reflects our expected tax rate on reported operating income before income tax including the favorable effect of the retroactive reinstatement of the 2017 BTC and Small Agri-biodiesel Producer Tax Credit. Our effective tax rate in the six months ended June 30, 2017 does not reflect the BTC and Small Agri-biodiesel Producer Tax Credit recognized in 2018 because these credits and incentives were ~~decreased~~retroactively extended through December 31, 2017 on February 9, 2018. This six-month effective rate is not expected to continue for the remainder of 2018 as these credits only benefited the three months ended March 31, 2018.

Unrecognized tax benefits totaled $0 at both June 30, 2018 and December 31, 2017.

NetIncome

Net income for the three and six months ended June 30, 2018 increased $5,217 and $37,647 as compared to the same periods in 2017. The increase was primarily from stronger sales volumes and a 14% reduction in the federal statutory tax rate. The first three months ended March 31, 2018 was benefited by tax credits and incentives that were not in effect for 2017 (see Note 2) but not in effect in the prior year. Also benefitting net income was the change in adjustments in the carrying value of our inventory as determined utilizing the LIFO method of inventory accounting. ~~This~~The change in this adjustment ~~decreased gross profit $837~~increased net income in the three and ~~$1,256~~six months of 2018 as compared to the same periods of 2017. Net income was further benefited from the absence of a lower or cost market write-down compared to the prior three and six months ended June 30, 2017.

ChemicalsSegment

	Three months ended June 30,									Six months ended June 30,
					Change									Change
	2018		2017		Amount		%			2018		2017		Amount		%

Revenues	$	31,527	$	23,351	$	8,176		35.0	%	$	60,608	$	49,708	$	10,900		21.9	%
Volume/product mix effect					$	8,111		34.7	%					$	9,472		19.1	%
Price effect					$	65		0.3	%					$	1,428		2.9	%

Gross profit	$	8,016	$	5,332	$	2,684		50.3	%	$	15,572	$	12,341	$	3,231		26.2	%

Sales revenue in the three and six months ended June 30, ~~2017, respectively,~~2018 increased $8,176 and $10,900 compared ~~a decrease of $515~~to the three and six months ended June 30, 2017. Sales revenue for our custom chemicals (unique chemicals produced for specific customers) for the three months and six months ended June 30, 2018 totaled $27,072 and $50,492, an increase of ~~$1,023~~$7,428 and $8,896 from the comparable periods, respectively in 2017. This increase was primarily attributed to increased sales volumes in the agrochemical and energy markets. In addition, the six-month comparison period sales were benefited from the change in the recognition of contract liabilities in deferred revenue for a few custom chemical contracts from the adoption of ASC 606. See Note 17 for additional discussion. Performance chemicals (comprised of multi-customer products, which are sold based on specification) sales revenues were $4,455 and $10,116, in the three and six months ended June 30, ~~2016, respectively. Also impacting gross profit in~~2018, an increase of $748 and $2,004 from the three and six months ended June 30, 2017, respectively. This increase was primarily from higher glycerin prices and the timing of the sales of products we campaign.

Gross profit for the chemicals segment for the three and six months ended June 30, 2018, increased $2,684 and $3,231 when compared to the three and six months ended June 30, 2017, respectively. This increase was driven primarily by higher volumes in the agrochemical and energy markets, and to a lesser extent, from a favorable product mix. For the three and six-month comparison period, gross profit was benefited by the change in ~~product mix.~~the recognition of contract liabilities in deferred revenue for a few customer chemical contracts given the adoption of ASC 606. See Note 17 for additional discussion.

Biofuels Segment

	Three months ended June 30,											Six months ended June 30,											Three months ended June 30,										Six months ended June 30,
						Change											Change											Change										Change
	2017			2016		Amount			%			2017			2016		Amount			%			2018		2017			Amount		%			2018		2017			Amount			%

Revenues	$	44,697		$	43,316	$	1,381			3.2	%	$	72,451		$	64,883	$	7,568			11.7	%	$	56,809	$	44,697		$	12,112		27.1	%	$	83,475	$	72,451		$	11,024			15.2	%
Volume/product mix effect						$	(10,521	)		(24.3	%)						$	(16,347	)		(25.2	%)						$	6,628		14.8	%						$	11,870			16.4	%
Price effect						$	11,902			27.5	%						$	23,915			36.9	%						$	5,484		12.3	%						$	(846	)		(1.2	%)

Gross profit	$	(3,534	)	$	1,675	$	(5,209	)		311.0	%	$	(4,413	)	$	4,156	$	(8,569	)		(206.2	%)	$	255	$	(3,534	)	$	3,789		107.2	%	$	30,206	$	(4,413	)	$	34,619			784.5	%

Biofuels sales revenue in the three and six months ended June 30, ~~2017~~2018 increased ~~$1,381~~$12,112 and ~~$7,568~~$11,024 when compared to the three and six months ended June 30, ~~2016.~~2017. This increase was primarily from ~~a favorable~~increased sales volumes and higher average selling prices. Sales price ~~variance on biodiesel, biodiesel RINS, and biodiesel blends. The sale of separated, internally generated RINs, comprised a larger component of revenue~~ in the ~~current quarter and six-month period as compared to the prior periods. Partially offsetting this increase was a reduction in pipeline sales which totaled $0 and $0 in the~~first three ~~and six~~ months ended ~~June 30,~~March 31, 2018 decreased primarily from the retroactive reinstatement of the 2017 ~~and $2,678 and $5,881 in the three and six months ended June 30 2016, respectively.~~ BTC (see Note 2).

Revenue from common carrier pipelines varies as its revenue recognition depends upon whether a transaction is bought from and sold to the same party. Purchases and sales of inventory with the same counterparty that are entered into in contemplation of one another (including buy/sell agreements) are combined and recorded on a net basis. Additionally, revenue from common carrier pipelines fluctuates with market conditions. Revenue from net transactions was zero in both of the three months ended June 30, 2018 and 2017.

A portion of our biodiesel sold in 2018 and 2017 was to ~~three major refiners/blenders in 2017 and~~ one major ~~refiner in 2016.~~refiner/blender. No assurances can be given that we will continue to sell to such major ~~companies,~~refiner, or, if we do sell, the volume we will sell or the profit margin we will realize. We do not believe that the loss of ~~these customers~~this customer would have a material adverse effect on our biofuels segment or on us as a whole in that: (i) unlike our custom manufacturing products, biodiesel is a commodity with a large potential customer base; (ii) we believe that we could readily sell our biodiesel to other customers as potential demand from other customers for biodiesel exceeds our production capacity; (iii) our sales to these customers are not under fixed terms and the customers have no fixed obligation to purchase any minimum quantities except as stipulated by short term purchase orders; and (iv) the prices we receive from these customers are based upon then-market rates, as would be the case with sales of this commodity to other customers.

Biofuels gross profit in the three and six months ended June 30, ~~2017 decreased $5,209~~2018 increased $3,789 and ~~$8,569~~$34,619 when compared to the three and six months ended June 30, ~~2016. Cost~~2017. The increase in the three-month period was primarily from higher sales volumes and improved petroleum margins. The increase for the six-month period was benefited from the recognition in the first quarter of ~~goods sold increased as a result~~2018 of the ~~absence~~retroactive reinstatement of the ~~blenders’ tax credit which expired December 31, 2016 and~~2017 BTC totaling $28,869. Also benefitting gross profit was ~~in effect in the prior year’s period. Gross profits were benefited by~~ the change in adjustments in the carrying value of our inventory as determined utilizing the LIFO method of inventory ~~accounting~~accounting. The change in this adjustment increased biofuels gross profit in the three and six months ~~ended June 30, 2017 as compared to~~of 2018 over the same ~~period~~periods of ~~2016. The LIFO adjustment decreased gross profit $2,435~~2017 by $732 and ~~$2,804,~~$2,333 and was further benefited from the absence of a lower or cost market write-down, which was $957 in the prior three ~~months ended June 30, 2017~~ and ~~2016, respectively. The LIFO adjustment decreased gross profit $3,893 in the~~ six months ended June 30, ~~2017 and increased~~2017.

Biofuels gross profit ~~in the six months ended June 30, 2016 $1,234. The LIFO adjustment resulted in a lower of cost or market adjustment of $938~~ in the three and six months ended June 30, ~~2016~~2018 was reduced by the change in activity in derivative instruments of $3,109 and ~~$957~~$3,271 in comparison to an increase in gross profit in the three and six months ended June 30, 2017 ~~respectively.~~

~~Biofuels gross profit was benefited by the change in the activity in~~ ~~derivative instruments. The unrealized and realized gain from derivative instruments activity was~~of $524 and ~~$1,803 in the three and six months ended June 30, 2017 and an unrealized and realized loss of $5,139 and $6,178 for the three and six months ended June 30, 2016.~~$1,803. In order to better manage the commodity price risk caused by market fluctuations in biofuel prices, we may enter into exchange traded commodity futures and options contracts. We account for these derivative instruments in accordance with accounting standards whereby the fair value of FutureFuel’s derivative instruments is determined based on the closing prices of the derivative instruments on relevant commodity exchanges at the end of an accounting period. Realized gains and losses on derivative instruments and changes in fair value of the derivative instruments are recorded in the statement of operations as a component of cost of goods sold within the biofuels segment.

FutureFuel recognizes all derivative instruments as either assets or liabilities at fair value in its consolidated balance sheet. ~~FutureFuel~~’sFutureFuel’s derivative instruments do not qualify for hedge accounting under the specific guidelines of ASC 815-20-25, Derivatives and Hedging. None of the derivative instruments are designated and accounted for as hedges due primarily to the extensive record keeping requirements.

The volumes and carrying values of ~~FutureFuel~~’sFutureFuel’s derivative instruments were as follows:

June 30, 2017

December 31, 2016

Quantity (contracts) Short

Fair Value

Quantity (contracts) Short

Fair
Value
Regulated options, included in other current assets^*

75

$
(520
)

-

$
-

Regulated fixed price future commitments, included in other current assets^*

35

$
(58
)
135

$
(258
)

	June 30, 2018					December 31, 2017
	Number of contracts Short		Fair Value			Number of contracts Short		Fair Value
Regulated options, included in other current assets		100	$	(940	)		200	$	(2,428	)
Regulated fixed price future commitments, included in other current assets		171	$	71			-	$	-

*All derivative instruments are entered into with the standard contract terms and conditions in accordance with major trading authorities of the New York Mercantile Exchange.

Critical Accounting Estimates

Revenue Recognition

On January 1, 2018, we adopted Topic 606 using the modified retrospective method applied to those contracts which were not completed as of January 1, 2018. Results for reporting periods beginning after January 1, 2018 are presented under Topic 606, while prior period amounts are not adjusted and continue to be reported in accordance with our historical accounting under Topic 605.

Certain long-term contracts had an upfront non-cancellable payment considered a material right. The Company applied the renewal option approach in allocating the transaction price to the material right. For each of these contracts the Company estimated the expected contractual volumes to be sold at the most likely expected sales price as a basis for allocating the transaction price to the material right. Each estimate will be updated quarterly on a prospective basis. These custom chemical contracts have payment terms of 30 days. Please see Note 17 for additional discussion.

For most product sales, revenue is recognized when product is shipped from our facilities and risk of loss and title have passed to the customer, which is in accordance with our customer contracts and the stated shipping terms. Nearly all custom manufactured products are manufactured under written ~~contracts.~~master service agreements. Performance chemicals and biodiesel are generally sold pursuant to the terms of written purchase orders. In general, customers do not have any rights of return, except for quality disputes. All of our products are tested for quality before shipment, and historically returns have been inconsequential. We do not offer rebates, except those related to the BTC, or other warranties.

Biodiesel selling prices can at times fluctuate based on the timing of unsold, internally generated RINs. From time to time, sales of biodiesel are on a “~~RINs-free”~~“RINs-free” basis. Such method of selling results in applicable RINs being held. The value of the RINs is not reflected in revenue until such time as the RIN sale has been completed.

Revenue from bill and hold transactions in which a performance obligation exists is recognized when the total performance obligation has been met and ~~title to~~control of the product has transferred. Bill and hold transactions for the three ~~and six~~ months ended June 30, ~~2017~~2018 and ~~2016~~2017 were related to ~~specialty~~custom chemicals customers whereby revenue was recognized in accordance with contractual agreements based upon product being produced and ready for ~~use.~~use by the customer. These sales were subject to written monthly purchase orders with agreement that production was reasonable. The ~~inventory~~product was custom manufactured and stored at the customer’s request and could not be sold to another buyer. Credit and payment terms for bill and hold customers are similar to other ~~specialty~~custom chemicals customers. Sales revenue under bill and hold arrangements were ~~$3,460~~$13,373 and ~~$4,019~~$3,460 for the three months ended June 30, 2018 and 2017, ~~and 2016, and $7,958 and $10,344 for~~respectively. For the six months ended June 30, 2018 and 2017, bill and ~~2016,~~hold inventory was $20,894 and $7,958, respectively.

Liquidity and Capital Resources

Our net cash provided by (used in) operating activities, investing activities, and financing activities for the ~~six~~three months ended June 30, ~~2017~~2018 and ~~2016~~2017 are set forth in the following chart.

	Six months ended June 30,						Six months ended June 30,
	2017			2016			2018			2017
Net cash provided by operating activities	$	27,959		$	46,028		$	65,360		$	27,959
Net cash used in investing activities	$	(10,774	)	$	(21,040	)
Net cash provided by/(used in) investing activities							$	25,182		$	(10,774	)
Net cash used in financing activities	$	(105,447	)	$	(5,437	)	$	(5,248	)	$	(105,447	)

OperatingActivities

Cash from operating activities ~~decreased~~increased from ~~$46,028~~ ~~of cash provided by operating activities in the first six months of 2016 to~~ $27,959 of cash provided by operating activities in the first six months of ~~2017.~~2017 to $65,360 of cash provided by operating activities in the first six months of 2018. This ~~decrease~~increase was primarily attributable to the increase of $37,647 in net income, the increase in the change in accounts payable, including accounts payable - related parties, of $20,539 offset by the decrease in ~~net income.~~the change in inventory of $18,964.

Investing Activities

Cash provided by investing activities increased $35,956, from cash used in investing activities ~~was $10,774~~of $10,774 in the first six months of 2017 compared to ~~$21,040 used~~$25,182 of cash provided by investing activities in the first six months of ~~2016. This~~2018. Of this change, $34,082 was ~~primarily~~ the result of net ~~purchases~~sales of marketable securities in the first six months of ~~2017~~2018 compared to ~~the first six months of 2016. Such~~ net purchases ~~totaled $9,054 and $15,775,~~ in the first six months of ~~2017 and 2016, respectively.~~2017. Such net sales totaled $25,028, in the first six months of 2018, compared to $9,054 in net purchases in the first six months of 2017. Our capital expenditures and customer reimbursements for capital expenditures are summarized in the following table:

	Six months ended June 30,						Six months ended June 30,
	2017			2016			2018			2017
Cash paid for capital expenditures and intangibles	$	1,686		$	2,254		$	1,103		$	1,686
Cash received as reimbursement of capital expenditures	$	(129	)	$	(119	)	$	(206	)	$	(129	)
Cash paid, net of reimbursement, for capital expenditures	$	1,557		$	2,135		$	897		$	1,557

Financing Activities

~~Cas~~hCash used in financing activities ~~increased~~decreased to $5,248 in the first six months of 2018 from $105,447 in the first six months of ~~2017 from $5,437 in the first six months of 2016.~~2017. This change is ~~primarily~~ the result of payments of dividends on our common stock in the first six months of ~~2017~~2018 compared to the first six months of ~~2016.~~2017. The payment of dividends totaled ~~$105,438~~$5,248 and ~~$5,246~~$105,438 in the first six months of 2018 and 2017, ~~and 2016,~~ respectively.

Credit Facility

Effective April 16, 2015, we entered into a new $150,000 secured committed credit facility with a syndicated group of commercial banks. On May 25, 2016, we increased the facility ~~$15,000~~.$15,000. The loan is a revolving facility, the proceeds of which may be used for our working capital, capital expenditures, and general corporate purposes. The facility terminates on April 16, 2020. See Note ~~6 – “Borrowings” in our consolidated financial statements ended June 30, 2017~~7 for additional information regarding our Credit Agreement.

We intend to fund future capital requirements for our businesses from cash flow as well as from existing cash, cash investments, and, if the need should arise, borrowings under our credit facility. We do not believe there will be a need to issue any securities to fund such capital requirements.

Dividends

In the first and second quarters of 2018, we paid a regular cash dividend in the amount of $0.06 per share on our common stock. The regular cash dividend amounted to $2,624 in the first and second quarters of 2018 for a total of $5,248. In the first two quarters of 2017, we paid a regular cash dividend in the amount of $0.06 per share on our common stock. The regular cash dividend amounted to $2,625 per ~~quarter in the first and second quarters of 2017.~~ quarter. In the first quarter of 2017, we also paid a special cash dividend of $2.29 per share on our common stock. This special cash dividend amounted to $100,188. Total cash dividends paid were $105,438 in the first six months of 2017.

~~In the first two quarters of 2016, we paid a~~ regular cash dividend in the amount of $0.06 per share on our common stock. The regular cash dividend amounted to $2,623 in the first quarter of 2016 and $2,623 in the second quarter of 2016, for aggregate dividend payments of $5,246 in the first six months of 2016.

Capital Management

As a result of our initial equity offering, our subsequent positive operating results, the exercise of warrants, and the issuance of shares in our at-the-market offering, we accumulated excess working capital. Some of this excess working capital has been paid out as special and regular cash dividends. Additionally, regular cash dividends will be paid in ~~2017,~~2018, as previously reported. Third parties have not placed significant restrictions on our working capital management decisions.

A significant portion of these funds was held in cash or cash equivalents at multiple financial institutions. In the periods ended June 30, ~~2017~~2018 and December 31, ~~2016,~~2017, we also had investments in certain preferred stock, trust preferred securities, exchange traded debt instruments, and other equity instruments. We classify these investments as current assets in the accompanying consolidated balance sheets and designate ~~them~~the debt securities as being “available-for-sale.” Accordingly, ~~they~~the debt securities are recorded at fair value, with the unrealized gains and losses, net of taxes, reported as a component of stockholders’ equity. We also held equity securities with readily available market values. These equity instruments are recorded at fair value, with the unrealized gains and losses in net income. The fair value of ~~these preferred stock, trust preferred~~the debt securities, ~~exchange traded debt instruments,~~ and ~~other~~ equity instruments totaled ~~$120,728~~$91,564 and ~~$106,146~~$120,699 at June 30, ~~2017~~2018 and December 31, ~~2016,~~2017, respectively.

Lastly, we maintain depositary accounts such as checking accounts, money market accounts, and other similar accounts at selected financial institutions.

Off- Balance Sheet Arrangements

We engage in two types of hedging transactions. First, we hedge our biofuels sales through the purchase and sale of futures contracts and options on futures contracts of energy commodities. This activity was captured on our balance sheet at June 30, ~~2017~~2018 and December 31, ~~2016.~~2017. Second, we hedge our biofuels feedstock through the execution of purchase contracts and supply agreements with certain vendors. These hedging transactions are recognized in earnings and were not recorded on our balance sheet at June 30, ~~2017~~2018 or December 31, ~~2016~~2017 because they do not meet the definition of a derivative instrument as defined under GAAP. The purchase of biofuels feedstock generally involves two risk components: basis and price. Basis covers any refining or processing required as well as transportation. Price covers the purchases of the actual agricultural commodity. Both basis and price fluctuate over time. A supply agreement with a vendor constitutes a hedge when we have committed to a certain volume of feedstock in a future period and have fixed the basis for that volume.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

All dollar amounts expressed as numbers in these Market Risk Disclosures are in thousands (except per share amounts).

In recent years, general economic inflation has not had a material adverse impact on our costs and, as described elsewhere herein, we have passed some price increases along to our customers. However, we are subject to certain market risks as described below.

Market risk represents the potential loss arising from adverse changes in market rates and prices. Commodity price risk is inherent in the chemicals and biofuels business both with respect to inputs (electricity, coal, raw materials, biofuels feedstock, etc.) and outputs (manufactured chemicals and biofuels).

We seek to mitigate our market risks associated with the manufacturing and sale of chemicals by entering into long-term sale contracts that include contractual market price adjustment protections to allow changes in market prices of key raw materials to be passed on to the customer. Such price protections are not always obtained, however, and some raw material price risk remains significant.

In order to manage price risk caused by market fluctuations in biofuels prices, we may enter into exchange traded commodity futures and options contracts. We account for these derivative instruments in accordance with ASC 815-20-25, Derivatives and Hedging. Under this standard, the accounting for changes in the fair value of a derivative instrument depends upon whether it has been designated as an accounting hedging relationship and, further, on the type of hedging relationship. To qualify for designation as an accounting hedging relationship, specific criteria must be met and appropriate documentation maintained. We had no derivative instruments that qualified under these rules as designated accounting hedges in the first ~~three~~six months of ~~2017~~2018 or ~~2016.~~2017. Changes in the fair value of our derivative instruments are recognized at the end of each accounting period and recorded in the statement of operations as a component of cost of goods sold within the biodiesel segment.

Our immediate recognition of derivative instrument gains and losses can cause net income to be volatile from period to period due to the timing of the change in value of the derivative instruments relative to the volume of biofuel being sold. As of June 30, ~~2017~~2018 and December 31, ~~2016,~~2017, the fair values of our derivative instruments were a net liability in the amount of ~~$578~~$869 and ~~$258,~~$2,428, respectively.

Our gross profit will be impacted by the prices we pay for raw materials and conversion costs (costs incurred in the production of chemicals and biofuels) for which we do not possess contractual market price adjustment protection. These items are principally comprised of crude corn oil and yellow grease and petrodiesel. The availability and price of these items are subject to wide fluctuations due to unpredictable factors such as weather conditions, overall economic conditions, governmental policies, commodity markets, and global supply and demand.

We prepared a sensitivity analysis of our exposure to market risk with respect to key raw materials and conversion costs for which we do not possess contractual market price adjustment protections, based on average prices for the first ~~three~~six months of ~~2017.~~2018. We included only those raw materials and conversion costs for which a hypothetical adverse change in price would result in a 1% or greater decrease in gross profit. Assuming that the prices of the associated finished goods could not be increased and assuming no change in quantities sold, a hypothetical 10% change in the average price of the commodity listed below would result in the following change in gross profit.

(Volume and dollars in thousands)

Item

Volume Requirements(a)

Units

Hypothetical Adverse Change in Price

Decrease in Gross Profit

Percentage Decrease in Gross Profit
Biodiesel Feedstocks

           157,091

LB

10%

$          4,524

57.1%
Ultra Low Sulfur Diesel

               5,937

GAL

10%

$             940

11.9%
Methanol

             51,015

LB

10%

$             837

10.6%
Electricity

             58

MWH

10%

$             261

3.3%
Natural Gas

           672

MCF

10%

$             230

2.9%
Sodium Methylate

               5,233

LB

10%

$             213

2.7%
Coal

             19

Ton

10%

$             121

1.5%

(a)   Volume requirements and average price information are based upon volumes used and prices obtained for the six months ended June 30, 2017.  Volume requirements may differ materially from these quantities in future years as our business evolves.

Item	Volume Requirements (a)		Units	Hypothetical Adverse Change in Price			Decrease in Gross Profit		Percentage Decrease in Gross Profit
Biodiesel feedstock		205,476	LB		10	%	$	5,363		11.7	%
Methanol		90,467	LB		10	%	$	1,710		3.7	%

(a) Volume requirements and average price information are based upon volumes used and prices obtained for the six months ended June 30, 2018. Volume requirements may differ materially from these quantities in future years as our business evolves.

We had no borrowings as of June 30, ~~2017~~2018 or December 31, ~~2016~~2017 and, as such, we were not exposed to interest rate risk for those periods. Due to the relative insignificance of transactions denominated in foreign currency, we consider our foreign currency risk to be immaterial.

Item 4. Controls and Procedures.

Under the supervision and with the participation of our chief executive officer and our principal financial officer and other senior management personnel, we evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15(d)-15(e)) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as of the end of the period covered by this report. Based on that evaluation, our chief executive officer and our principal financial officer have concluded that these disclosure controls and procedures as of June 30, ~~2017~~2018 were effective to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms.

There were no changes in our internal control over financial reporting during our last fiscal quarter that materially affected, or were reasonably likely to materially affect, our internal control over financial reporting.

PART II OTHER INFORMATION

Item 1. Legal Proceedings.

We are not a party to, nor is any of our property subject to, any material pending legal proceedings, other than ordinary routine litigation incidental to our business. However, from time to time, we may be a party to, or a target of, lawsuits, claims, investigations, and proceedings, including product liability, personal injury, asbestos, patent and intellectual property, commercial, contract, environmental, antitrust, health and safety, and employment matters, which we expect to be handled and defended in the ordinary course of business. While we are unable to predict the outcome of any matters currently pending, we do not believe that the ultimate resolution of any such pending matters will have a material adverse effect on our overall financial condition, results of operations, or cash flows. However, adverse developments could negatively impact earnings or cash flows in future periods.

Item 1A. Risk Factors.

There have been no material changes to the risk factors we previously disclosed in Item 1A of our Form 10-K, Annual

Report for the year ended December 31, ~~2016~~2017 filed with the SEC on March 16, ~~2017.~~2018.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

None.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures.

None.

Item 5. Other Information.

None.

Item 6. Exhibits.

Exhibit	Description
~~10.1~~	~~Retirement Consulting Letter Agreement dated June 13, 2017 between FutureFuel Chemical Company and Samuel W. Dortch~~
11.	Statement re Computation of per Share Earnings
31(a).	Rule 13a-15(e)/15d-15(e) Certification of chief executive officer
31(b).	Rule 13a-15(e)/15d-15(e) Certification of chief principal officer
32.	Section 1350 Certification of chief executive officer and principal financial officer
101	Interactive Data Files**
101.INS	XBRL Instance
101.SCH	XBRL Taxonomy Extension Schema
101.CAL	XBRL Taxonomy Extension Calculation
101.DEF	XBRL Taxonomy Extension Definition
101.LAB	XBRL Taxonomy Extension Labels
101.PRE	XBRL Taxonomy Extension Presentation
**	Pursuant to Rule 406T of Regulation S-T, the Interactive Data Files in Exhibit 101 hereto are deemed not filed or part of a registration statement or prospectus for purposes of Section 11 or 12 of the Securities Act of 1933, as amended, are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise are not subject to liability under those sections.

Special Note Regarding Forward Looking Information

This report, and the documents incorporated by reference into this report contain forward-looking statements. Forward- looking statements deal with our current plans, intentions, beliefs, and expectations, and statements of future economic performance. Statements containing such terms as “believe,” “do not believe,” “plan,” “expect,” “intend,” “estimate,” “anticipate,” and other phrases of similar meaning are considered to contain uncertainty and are forward-looking statements. In addition, from time to time we or our representatives have made or will make forward-looking statements orally or in writing. Furthermore, such forward-looking statements may be included in various filings that we make with the SEC, or in press releases, or in oral statements made by or with the approval of one of our authorized executive officers.

These forward-looking statements are subject to certain known and unknown risks and uncertainties, as well as assumptions that could cause actual results to differ materially from those reflected in these forward-looking statements. Factors that might cause actual results to differ include, but are not limited to, those set forth under the headings “Risk Factors” and ~~“Management~~’s“Management’s Discussion and Analysis of Financial Condition and Results of Operations” in FutureFuel’s Form 10-K Annual Report for the year ended December 31, ~~2016~~2017 and in our future filings made with the SEC. You should not place undue reliance on any forward-looking statements contained in this report which reflect our management’s opinions only as of their respective dates. Except as required by law, we undertake no obligation to revise or publicly release the results of any revisions to forward-looking statements. The risks and uncertainties described in this report and in subsequent filings with the SEC are not the only ones we face. New factors emerge from time to time, and it is not possible for us to predict which will arise. There may be additional risks not presently known to us or that we currently believe are immaterial to our business. In addition, we cannot assess the impact of each factor on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. If any such risks occur, our business, operating results, liquidity, and financial condition could be materially affected in an adverse manner. You should consult any additional disclosures we have made or will make in our reports to the SEC on Forms 10-K, 10-Q, and 8-K, and any amendments thereto. All subsequent written and oral forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the cautionary statements contained in this report.

S I G N A T U R E S

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

FUTUREFUEL CORP.

By:	/s/ Paul A. Novelly

Paul A. Novelly, Chairman and Chief
Executive Officer

Date: August 9, ~~2017~~ 2018


By:	/s/ Rose M. Sparks

Rose M. Sparks, Chief Financial Officer
and Principal Financial Officer

Date: August 9, ~~2017~~ 2018

2834

	June 30, 2017					December 31, 2016
	Quantity (contracts) Short		Fair Value			Quantity (contracts) Short		Fair Value
Regulated options, included in other current assets^*		75	$	(520	)		-	$	-
Regulated fixed price future commitments, included in other current assets^*		35	$	(58	)		135	$	(258	)

Item	Volume Requirements(a)	Units	Hypothetical Adverse Change in Price	Decrease in Gross Profit	Percentage Decrease in Gross Profit
Biodiesel Feedstocks	157,091	LB	10%	$ 4,524	57.1%
Ultra Low Sulfur Diesel	5,937	GAL	10%	$ 940	11.9%
Methanol	51,015	LB	10%	$ 837	10.6%
Electricity	58	MWH	10%	$ 261	3.3%
Natural Gas	672	MCF	10%	$ 230	2.9%
Sodium Methylate	5,233	LB	10%	$ 213	2.7%
Coal	19	Ton	10%	$ 121	1.5%
(a) Volume requirements and average price information are based upon volumes used and prices obtained for the six months ended June 30, 2017. Volume requirements may differ materially from these quantities in future years as our business evolves.